| V4 |
Impact of Anderson-Fabry disease-causing mutations on excitation-contraction coupling of cardiac myocytes |
| V5 |
Differential cAMP responses in the human heart: role of phosphodiesterases |
| V6 |
Renal denervation reduces atrial remodeling and risk of atrial fibrillation in a rat model of CKD |
| V7 |
Microdomain targeted cAMP biosensors reveal switched beta-adrenergic responses on calcium handling-related compartments in atrial fibrillation |
| V8 |
Cardiovascular risk of NSAID: Diclofenac, ketoprofen and naproxen increase ventricular vulnerability in a sensitive experimental model |
| V9 |
Dantrolene reduces CaMKII-mediated arrhythmogenesis in atrial fibrillation |
| V98 |
Inhibition of microRNA-146a triggers prohealing macrophage polarization in myocardial infarction in mice |
| V99 |
DNA-dependent protein kinase (DNA-PK) mediates Y box binding-protein-1 (YB-1) activation |
| V100 |
Inactivation of HDAC2 alters atrial intracellular calcium dynamics in mice |
| V101 |
Identification of 15 novel isoforms and a novel promoter region of PGC1-a in the murine and human heart by full-length-transcriptomics using Single-Molecule Real-time Sequencing (SMRT) |
| V102 |
Circular RNAs in cardiac energy metabolism |
| V103 |
Role of telomerase in doxorubicin mediated cardiotoxicity |
| V104 |
DNA methyltransferase 1 is required for heart development |
| V105 |
Hypertrophic Cardiomyopathy: Stem cell-derived cardiomyocytes with ß-myosin mutation Arg723Gly show altered function and unequal allelic expression of ß-MyHC |
| V106 |
Impact of obesity on complications of catheter ablation for cardiac arrhythmias |
| V107 |
Recurrence of atrial fibrillation after cryoballoon pulmonary vein isolation in obesity – Does weight make a difference? |
| V108 |
Improved Cardiopulmonary Exercise Capacity in Asymptomatic Patients with Persistent Atrial Fibrillation after Successful Ablative Treatment |
| V109 |
Cardiopulmonary exercise capacity before and after ablative treatment of symptomatic atrial fibrillation in patients with normal left ventricular systolic function: 1 year follow-up |
| V110 |
Habitual activity levels in patients with atrial fibrillation decrease with increasing sleep apnea severity, but not with atrial fibrillation burden |
| V111 |
Is there a bidirectional relationship between sleep-disordered breathing and atrial fibrillation? |
| V112 |
Outcome of paroxysmal atrial fibrillation ablation in patients with and without pathological apnea-hypopnea-index using a simple screening device |
| V113 |
Catheter ablation of isthmus-dependent atrial flutter and AV nodal reentry tachycardia in the very elderly patients over 80 years of age |
| V114 |
Safety and efficacy of catheter ablation for atrial and ventricular arrhythmias in octogenarians |
| V115 |
Gender specific distribution of left ventricular ejection fraction in acute heart failure – a latent class analysis |
| V116 |
Incidence and Clinical Impact of Right Ventricular Involvement (Biventricular ballooning) in Takotsubo syndrome: Results from the GEIST Registry |
| V117 |
Detection of Takotsubo Syndrome using Artificial Intelligence in Echocardiography |
| V118 |
Long-term mortality in TakoTsubo patients treated with different antiaggregation therapy |
| V119 |
Clinical phenotypes of Tako-Tsubo Cardiomyopathy: Contraction patterns and their impact on long-term survival |
| V120 |
Adrenoceptor signaling contributes to arrhythmogenesis of Takotsubo Cardiomyopathy |
| V121 |
High number of CD45RO positive cells in endomyocardial biopsies is associated with increased mortality of patients with inflammatory cardiomyopathy |
| V122 |
Sepsis-induced acute heart failure is driven by MEF2D-dependent transcription |
| V123 |
SIRT1-overexpression improves insulin sensitivity in heart and skeletal muscles in severe sepsis of mice |
| V124 |
Circulating Th17 and Th22 cells are associated with CMR imaging biosignatures of diffuse myocardial interstitial remodeling in ischemic heart disease |
| V125 |
Local atrial myopathy is the foundation for atrial fibrillation |
| V126 |
Systematic review & meta-analysis on the diagnostic accuracy of vasodilator myocardial perfusion cardiac MRI and dobutamine stress echocardiography for the detection of relevant CAD |
| V127 |
Impact of Infarct Location and Size on Clinical Outcome after ST-elevation Myocardial Infarction treated by Primary Percutaneous Coronary Intervention |
| V128 |
The Adipokine Fatty-Acid Binding Protein 4 and Cardiac Remodeling |
| V129 |
Prognostic impact of Late Gadolinium Enhancement in patients at risk for sustained ventricular arrhythmia wearing the wearable cardioverter-defibrillator – a bicentric observational study |
| V130 |
Molecular Imaging of Chemokine Receptor CXCR4 Early After Myocardial Infarction Predicts Left Ventricular Remodeling |
| V171 |
Ausdauertraining früh nach ST-Hebungsinfarkt und Auswirkungen auf das kardiale Remodeling – Echokardiographische Ergebnisse der Ex-AMI-Studie |
| V172 |
Supervised exercise training in patients with chronic thromboembolic pulmonary hypertension (CTEPH) as early follow-up treatment after pulmonary endarterectomy (PEA) – a prospective cohort study |
| V173 |
Establishment of a fitness center course for improvement of coordination skills, cardiopulmonary capacity and quality of life in cancer patients |
| V174 |
Impact of exercise training on vascular markers and aortic diameter in patients with small abdominal aortic aneurysms |
| V175 |
A lower workload adjusted blood pressure response is associated to an enhanced right ventricular- arterial coupling in elite indoor athletes |
| V176 |
Improved circulatory and ventilatory efficiency during exercise in patients with chronic thromboembolic disease after invasive treatment by pulmonary endarterectomy or pulmonary balloon angioplasty |
| V187 |
Pharmacological inhibition of the acetylcholine-regulated potassium channel (IK,ACh) prevents atrial arrhythmogenic changes in a rat model for obstructive sleep apnea |
| V188 |
Ischemic heart failure enhances atrial arrhythmogenicity in a porcine model |
| V189 |
Electrophysiologic properties of sacubitril in an experimental whole-heart model |
| V190 |
Characterization of cardiac ventricular sympathetic denervation in a mouse model |
| V191 |
Development of a 2-component cardiac organoid model to study hiPSC-CM pacemaker function |
| V192 |
Dexmedetomidine reduces ventricular arrhythmias in a model of drug-induced QT-prolongation |
| V193 |
Multidetector computed tomography substrate modeling in patients with structural heart disease and internal cardioverter defibrillator undergoing catheter ablation of ventricular tachycardia |
| V194 |
Reduced sympathetic innervation is associated with specific local abnormal ventricular potentials in patients undergoing catheter ablation of scar-related ventricular arrhythmias |
| V195 |
Ultra High-Density Mapping in Catheter Ablation of Ventricular Tachycardia: Is it worth the Effort? |
| V196 |
Modification of Myocardial Ischemic Scar Arrhythmogenic Substrate Through Proton Beam Therapy: Tissue effects and Imaging Biomarkers in a Porcine Model |
| V197 |
Modification of Myocardial Ischemic Scar Arrhythmogenic Substrate Through Proton Beam Therapy: Safety Profile in a Porcine Model |
| V198 |
Interdisciplinary target volume generation for cardiac radiosurgery: Lessons learned from the first multi-center benchmark case for the RAdiosurgery for VENtricular TAchycardia (RAVENTA) trial |
| V199 |
Acute Hemodynamic Changes and Long-Term Prognostic Impact of Pulmonary Hypertension in Patients Undergoing Percutaneous Mitral Valve Edge-to-Edge Repair |
| V200 |
Impact of Mean Arterial Pressure to Right Atrial Pressure Ratio on outcome after successful percutaneous edge-to-edge-repair for severe mitral valve regurgitation |
| V201 |
Hemodynamic effects of iatrogenic arterial septal defect closure after Mitraclip-Implantation – a pressure volume loop study |
| V202 |
Differentiation of pre-, post- and combined pre/post-capillary pulmonary hypertension by right heart catheter as a predictor of mortality in patients undergoing MitraClip® therapy |
| V203 |
First wireless right atrial pressure measurement in patients with severe tricuspid regurgitation before and after percutaneous or surgical treatment |
| V204 |
Pulmonary capillary wedge pressure (PCWP) as prognostic indicator in patients undergoing transcatheter valve repair (TTVR) of severe tricuspid regurgitation |
| V205 |
Clinical Impact of sex-specific cutoff values for high-sensitivity cardiac troponin i to diagnose acute myocardial infarction |
| V206 |
The impact of age on the diagnostic specificity of high-sensitivity troponin I and T to identify acute myocardial infarction |
| V207 |
Clinical relevance of elevated copeptin levels in patients with suspected acute coronary syndrome |
| V208 |
Clinical application of the fourth universal definition of myocardial infarction using FDA-recommended sex-specific cut-offs |
| V209 |
Application of the 4th universal definition of myocardial infarction in patients with hypertensive crisis |
| V213 |
Schnelle T1rho-Dispersionsbildgebung zur verbesserten Charakterisierung des Myokardgewebes bei Mäusen mittels synthetischer Dispersionsrekonstruktion |
| V214 |
The feasibility of right ventricular T2* measurements at ultra-high-field MRI |
| V215 |
A 150-fold Speed-up in LV Segmentation Through Deep Learning – A Transfer Application to 7T CINE Data |
| V216 |
Artificial intelligence based fully automated myocardial function assessment for diagnostic and prognostic stratification following myocardial infarction |
| V217 |
An MRI-conditional cardiac phantom simulating cardiac anatomy and function and enabling training of interventional CMR procedures: first use regarding right-heart catheterization |
| V218 |
Feasibility of Cardiac Magnetic Resonance based CRT Optimization |
| V234 |
Nitro oleic acid protects from adverse cardiac remodeling in a murine model of hypertensive heart failure |
| V235 |
Activation of NR4A receptors is a novel vascular anti-inflammatory response: Insights from endocannabinoids |
| V236 |
Distinct Neutrophil Activation Patterns at the Site of Coronary Culprit Lesions in Acute Coronary Syndrome with Intact Fibrous Cap (IFC-ACS) – Results from the Multicentric OPTCIO-ACS Study |
| V237 |
Glypican-4 expression is reduced in the inflammatory plaque shoulder in human atherosclerotic lesions |
| V238 |
Die PI 3-kinase Isoform p110a in glatten Gefäßmuskelzellen schützt vor der Progression aortaler Aneurysmata |
| V239 |
Nitro-oleic acid reduces thoracic aortic aneurysm progression in a mouse model of Marfan syndrome |
| V240 |
Alginate hydrogels-mediated delivery of vascular-specific adeno-associated virus vectors in aortic tissue |
| V241 |
IKK?/NEMO localization into multivesicular bodies |
| V242 |
Pro-efferocytic single-walled carbon nanotubes restore phagocytic activity of lesional macrophages to combat atherosclerosis |
| V243 |
Inflammation and infarct healing following acute ST-elevation myocardial infarction |
| V244 |
C-reactive protein increases myocardial damage after STEMI |
| V245 |
Myocardial injury rather than type of myocardial infarction is associated with monocyte subsets |
| V246 |
CXCL14 levels are differentially regulated in patients with acute coronary syndrome and associated with impaired left ventricular function after acute myocardial infarction |
| V247 |
Calprotectin is associated with changes in monocyte subsets in acute myocardial infarction |
| V248 |
Peptide YY (PYY) is associated with increased mortality in patients after acute myocardial infarction |
| V249 |
The gut incretin hormone GIP is downregulated in patients with acute myocardial infarction |
| V250 |
The gut hormone GLP-2 predicts cardiovascular risk in patients with acute myocardial infarction |
| V251 |
Serum MicroRNA-21 Levels are suppressed in Myocardial Infarction and Stable Coronary Heart Disease when compared to patients with rule out of coronary artery disease by coronary angiography |
| V252 |
Leitliniengerechte medikamentöse Therapie der Herzinsuffizienz bei nicht-ischämischer Kardiomyopathie – Von der klinisch relevanten Frage zur möglichen Antwort anhand einer retrospektiven Datenanalyse |
| V253 |
Diagnostic yield of targeted versus broad next generation sequencing data analysis in inherited cardiomyopathy and arrhythmia syndromes |
| V254 |
Establishment of high-throughput nanopore sequencing of tissue samples from cardiomyopathy patients |
| V255 |
Dilative cardiomyopathy-causing Rbm20 mutation provokes mitochondrial reactive oxygen species emission in cardiac myocytes associated with elevated myofilament activation |
| V256 |
A lipid metabolism defect caused by mitochondrial dysfunction contributes to cardiomyopathy in Barth Syndrome (BTHS) |
| V257 |
Recapitulation of dilated cardiomyopathy caused by lamin A/C mutation in mouse embryonic stem cell using CRISPR-Cas9 |
| V258 |
The role of the nuclear envelope protein LEMD2 in the development of cardiomyopathy |
| V259 |
A novel STRIPAK associated cardiac Kinase is upregulated in human cardiomyopathy and controls cardiomyocytes hypertrophy and apoptosis |
| V260 |
Identification of a novel cardiac splicing regulator involved in dilated cardiomyopathy |
| V261 |
Obesity promotes myelopoiesis after acute myocardial infarction |
| V262 |
Obstruktive Schlafapnoe ist bei Patienten mit akutem Myokardinfarkt mit dem Vorhandensein koronarer Kollateralen assoziiert |
| V263 |
Platelet complement C3 deposition predicts platelet hyperactivity in patients with type II diabetes |
| V264 |
A supervised 16 week exercise intervention in patients with metabolic syndrome improved cardiorespiratory fitness, regardless of exercise intensity, and volume, but had no effect on metabolic control |
| V265 |
Inter-individual differences in the response to an exercise training intervention in patients with metabolic syndrome |
| V266 |
Treatment of SDB reduces arrhythmic events in HF patients |
| V267 |
Cryoballoon- versus Radiofrequency-based Pulmonary Vein Isolation in Obese Patients: Results of a Single-Center Analysis |
| V268 |
How long are intensive prevention programs after myocardial infarction needed? -The randomized IPP „Prevention Boost“ Trial- |
| V269 |
Patientenberichtete „Outcomes“ als Determinanten von beruflicher Wiedereingliederung und Lebensqualität nach kardiologischer Rehabilitation: Ergebnisse des multizentrischen Registers OutCaRe |
| V390 |
Current spectrum and 1-year mortality of cardiogenic shock in Europe. Results of the CULPRIT-SHOCK randomized clinical trial and registry |
| V391 |
Multivessel versus Culprit-only PCI in STEMI Patients with Multivessel Disease: Meta-Analysis of Randomized Controlled Trials |
| V392 |
Long-term Outcome After Thrombus Aspiration In Non-ST-Elevation Myocardial Infarction – Results From The TATORT-NSTEMI Trial |
| V393 |
Weser reacts on ISAR – „real world“-Daten zum Vergleich zwischen Ticagrelor und Prasugrel |
| V419 |
Impact of pulmonary vein isolation on heart-focused anxiety, general anxiety, depression and chronic stress in patients with atrial fibrillation |
| V420 |
Concomitant ablation of “permanent” atrial fibrillation? 2 years success – correlation to metabolic parameters and ventricular remodeling |
| V421 |
A comparison between different ablation methods in terms of radiation exposure and procedural parameters over seven years – a single center study |
| V422 |
Left atrial size as predictor of success after ablation of atrial fibrillation: which echocardiographic method to use? |
| V423 |
The German Cardiosurgical Atrial Fibrillation Registry (CASE-AF): In-Hospital Outcomes |
| V424 |
Ablation of atrial fibrillation in hypertrophic cardiomyopathy: treatment strategy, long-term outcome, prevalence and mechanism of atrial tachycardias |
| V461 |
Pacemaker Mechanisms of Human Induced Pluripotent Stem-Cell Derived Cardiomyocytes in Engineered Heart Tissue |
| V462 |
Mechanisms of endothelial cell activation by endocannabinoid 2-arachidonoylglycerol |
| V463 |
Crosstalk between adenosine-A2BR and hypoxia-HIF-1a signalling in post-MI epicardial stromal cells |
| V464 |
Extracellular vesicle-incorporated miR-130 regulates endothelial healing in coronary artery disease patients with chronic kidney disease |
| V465 |
Sarcomere microdomain destabilization assessed with iPSC-derived cardiomyocytes from dilated cardiomyopathy patients and CRISPR/Cas9 engineered isogenic controls |
| V466 |
Robust cardiac regeneration from cardiac stromal cells is mediated by T-cells |
| V467 |
Single-cell expression profiling of post-MI epicardial stromal cells reveals substantial heterogeneity and distinct cellular hierarchy |
| V468 |
Evaluation of cardiomyocyte proliferation after transplantation of engineered heart tissue patches |
| V469 |
The Long Non-Coding RNA MALAT1 Is Required For Cardiomyocytes Proliferation and Postnatal Cardiac Regeneration |
| V470 |
Coronary Plaque Ulcerations – Novel Features of Plaque Vulnerability in ACS with Intact Fibrous Cap? – Insights from the OPTICO-ACS Study Program |
| V471 |
Effectiveness of an intensified antithrombotic strategy for treatment of post-angiography radial artery occlusion – first insights of the ProRadial study |
| V472 |
Usefulness of troponin in selecting patients for invasive coronary angiography after cardiac surgery |
| V473 |
Influence of systolic versus diastolic timing on the accuracy of simulated FFRangio: comparison with invasive FFR |
| V474 |
Predictive value of systolic and diastolic function in the general population – Results from the population based Gutenberg Health study |
| V475 |
Cardiac proteomic analyses, titin changes, and effect of spermidine therapy in a rat HFpEF model |
| V476 |
Alterations in arginine metabolism in ZSF1 rats – an animal model for HFpEF |
| V477 |
PLK2 controls osteopontin-driven myofibrosis and left ventricular diastolic dysfunction |
| V478 |
Effects of SGLT-1/2 inhibition with Sotagliflozin on cardiac function, remodeling and cardiomyocyte myofilament sensitivity in a metabolic-based HFpEF model |
| V479 |
SGLT-1/2i Sotagliflozin’s mode-of-action on left atrial remodeling in HFpEF |
| V480 |
Empagliflozin Leads to a Rapid and Sustained Improvement of Diastolic Function in Patients with Type 2 Diabetes |
| V481 |
Skeletal muscle metabolism characteristics of patients with HFpEF and HFrEF |
| V482 |
HFpEF and MitraClip – Do patients with elevated left atrial and ventricular pressures benefit from MitraClip? |
| V483 |
Sharp Rises in Fibroblast Growth Factor 23 (FGF23) and ensuing severe hypophosphatemia after single i.v. iron administration do not cause additional myocardial damage in heart failure patients |
| V484 |
Evaluation of TIMP2 and UCP2 as biomarkers of right ventricular remodeling in pulmonary hypertension |
| V485 |
The role of the secreted modular calcium binding protein 1 in platelet function |
| V486 |
Stromal vascular cells of murine epididymal adipose tissue is capable of producing extracellular Inflammasome Particles |
| V487 |
Multi-omics approach to post-CABG renal impairment |
| V488 |
Head-to-head comparison on the incremental value of the three established risk markers hs-troponin I, hs-C-reactive protein and NT-proBNP in secondary prevention of coronary artery disease |
| V489 |
Hepatocyte growth factor as a non-invasive biomarker in chronic thromboembolic pulmonary hypertension |
| V490 |
Coronary artery disease ameliorates extracellular vesicle lncRNA PUNISHER that regulates antigenic response and endothelial cells function via NFkB-dependent mechanism |
| P491 |
Identifying the role of cardiolipins for cardiac function of Drosophila melanogaster |
| P492 |
Evaluation of effects of the N-terminal fragment of cardiac myosin binding protein-C on cardiac fibroblasts |
| P493 |
Long Distance Modulation of Cardiac Fibroblast Adaptations to Matrix Stiffness: Relevance for Fibrosis vs. Homeostasis |
| P494 |
Vascular endothelial protein tyrosine phosphatase modulates eNOS phosphorylation on Tyr81 and eNOS activity |
| P495 |
The role of ceramides in cardiac protein homeostasis |
| P496 |
Degenerative aortic valve disease triggers a complex cardio-pulmonary phenotype in New Zealand Obese mice |
| P497 |
Analysis of the intercalated disc composition in hypertrophic cardiomyopathy revealed enhanced expression and sarcomeric mislocalisation of nebulin-related anchoring protein |
| P498 |
Impact of gender and estrogen-based signaling on titin properties in rat hearts and isolated cardiomyocytes |
| P499 |
Characterization of the Hippo pathway during cardiomyogenesis and effects of angiotensin II stimulation in cardiomyocytes derived from human iPS cells |
| P500 |
Environmental noise aggravates oxidative DNA damage, granulocyte oxidative burst and nitrate resistance in Ogg1-/- mice |
| P501 |
Specific Ceramide Synthase 2 overexpression leads to increased proinflammatory ceramides and subsequently impairs mitochondrial function leading to cell death and fibrosis progression |
| P502 |
Doxorubicin induced lipotoxicity is mediated by abnormal lipid metabolism, ceramide accumulation and impaired mitochondrial function in human fibroblasts |
| P503 |
Dorsomorphin stabilises endothelial junctions and barrier function via Rac1 activation: Role of dorsomorphin-induced Ca2+ release |
| P504 |
HIF1a-AS1 is a DNA:DNA:RNA triplex forming lncRNA recruiting the HUSH complex to control endothelial gene expression |
| P505 |
Eine Kardiomyozyten-spezifische Deletion der Monoaminooxidase B (MaoB) reduziert die Infarktgröße |
| P506 |
Primary human epicardial adipocytes possess a memory: differential release and expression of PCSK9 depending on patient’s age and nutritional status |
| P507 |
Inhibition of lipolysis improves cardiac function after ischemia/reperfusion |
| P508 |
Insulin like growth factor-1 but not Insulin induces macrophage polarization towards an anti-inflammatory M2-like phenotype |
| P509 |
Hyperglycemia-induced endothelial dysfunction is alleviated by thioredoxin mimetic peptides through the restoration of Vascular Endothelial Growth Factor Receptor (VEGFR) signalling |
| P510 |
Characterization of red blood cell integrity and endothelial function in a murine model of aortic valve stenosis |
| P511 |
Vasodilation of tea polyphenols ex vivo is mediated by hydrogen peroxide under rapid compound decay |
| P512 |
Tissue-specific regulation of the mitochondrial proteome by adiponectin receptor 1 |
| P513 |
Metabolic Pericyte-Endothelial Cross-Talk |
| P514 |
Cardiac contractility is regulated by insulin in a protein kinase B dependent manner |
| P515 |
Hypertensive organ damage in response to Angiotensin II depends on microbial colonization |
| P516 |
Cathelicidins interfere with neutrophil-monocyte interaction in angiotensin II driven arterial hypertension but do not influence blood pressure or vascular endothelial dysfunction |
| P517 |
Myocardial fibrosis induced by chronic kidney disease in the murine remnant kidney model is independent of arterial hypertension |
| P518 |
The SGLT2 inhibitor ertugliflozin reduces cardiac fibrosis and modulates cardiac substrate metabolism in a mouse model of cardiac hypertrophy |
| P519 |
L-2-hydroxyglutarate dehydrogenase (L2HGDH) is a novel target for heart failure due to pressure overload |
| P520 |
Redox-activated protein kinase A Type I (PKA RI) exerts a protective role during pathological pressure overload |
| P521 |
Myozap plays crucial role in Dysbindin-mediated cardiac hypertrophy |
| P522 |
Hypertrophy is provoked by diabetic conditions in induced pluripotent stem cell-derived cardiomyocytes and is reduced by nitro-oleic acid |
| P523 |
Ceramide accumulation inhibits insulin-dependent phosphorylation of Akt in human-induced pluripotent stem cells derived cardiomyocytes |
| P524 |
Longitudinal metabolic profiling of cardiomyocytes derived from human-induced pluripotent stem cells |
| P525 |
Metabolic and molecular analysis of cardiomyocytes derived from human-induced pluripotent stem cells exposed to diabetic conditions |
| P526 |
Soluble adenylyl cyclase affects akt and camkii activity in adult rat cardiomyocytes, but not in h9c2 cells. Are h9c2 cells really cardiomyocyte-like? |
| P527 |
Drug effects on gating kinetics of hERG channels in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with short QT syndrome type 1 |
| P528 |
Intronic CRISPR repair in LZTR1-deficient iPSC-cardiomyocytes from Noonan syndrome patients rescues disease phenotype |
| P529 |
Establishment of a protocol for differentiation and phenotypical characterization of human induced pluripotent stem cell-derived vascular smooth muscle cells |
| P530 |
Differences in scientific publishing between women and men are greater in cardiology than in cardiac or general surgery |
| P531 |
New and classical methods to compare oxidative stress levels and parameters of vascular function in rat models of hypertension, diabetes and nitrate tolerance |
| P532 |
Fat body lipolysis determines survival and cardiac function during starvation in Drosophila melanogaster |
| P533 |
Histo-morphologische und mechanische Evaluation bovinen Perikards zur Anwendung in kardiovaskulären Implantaten |
| P534 |
K+-based Optogenetic Silencing of Cardiomyocytes |
| P535 |
Apolipoprotein B-specific aß T cell receptors and single cell transcriptomes of oligoclonal regulatory CD4 T cells in vaccinated mice |
| P536 |
Reconstruction of Contracting Cardiomyocytes With Nanometer Resolution |
| P537 |
CD40L acts as a novel adhesion factor in acute vascular inflammation |
| P538 |
S1P reduces septic hyperpermeability via actin cytoskeletal remodeling and MRTF-A nuclear translocation |
| P539 |
Sphingosine-1-phosphate effects on vascular remodeling after arterial occlusion |
| P540 |
Elevated circulating Platelet-Leukocyte Complexes in Myocardial infarction: a marker not a pathogen |
| P541 |
Myeloperoxidase as a potential mediator for inflammation-induced vascular dysfunction in obesity |
| P542 |
Pyk2-inhibition Restores Organ-Protective Heterocellular Communication Induced by rIPC in Hyperinsulinemia and Insulin Resistance |
| P543 |
A novel large animal model of thrombogenic coronary microembolization |
| P544 |
Transduction of Endothelial Cells with Recombinant Adeno-Associated Virus |
| P545 |
Assessment of genetic variants in patients with coronary spasm reveals novel insights into pathophysiology |
| P546 |
CaM Kinase II regulates cardiac hemoglobin expression through histone phosphorylation upon sympathetic activation |
| P547 |
Zinc-independent acid sphingomyelinase activity alone is responsible for elevated serum activity in chronic heart failure rats |
| P548 |
Clinically assessed severity of human heart failure correlates with mitochondrial dysfunction |
| P549 |
ID1 ist für die Aufrechterhaltung der kardialen Funktion essentiell und metabolischer Stress führt zu einer anhaltenden Aktivierung seines Enhancers |
| P550 |
Neuregulin-1 during acute myocardial infarction and its association with circulating monocyte subsets |
| P551 |
The “correct” distance between mitochondria and SR is necessary to ensure intact metabolic coupling |
| P552 |
Altered PKA-dependent phosphorylation of calcium handling proteins and impaired ß-adrenergic response in ventricular myocytes from Cacna1c+/- rats |
| P553 |
Modulation of myocardial injury and arrhythmogenicity by Galectin-3 in a murine model of ischemia and reperfusion |
| P554 |
Variable clinical phenotype associated with HCN4 mutations comprising sinus node dysfunction, atrial tachyarrhythmias and structural cardiac alterations |
| P555 |
The role of microRNA-365 in the regulation of human cardiac action potential |
| P556 |
The relevance of the Gq pathway for atrial pro-arrhythmic Ca2+ release |
| P557 |
High resolution mapping of focal VT from the papillary muscle: heterogeneity of activation recovery interval |
| P558 |
Altered cardiac electrophysiology in mice deficient for the neuron-specific HCN interaction partner TRIP8b |
| P559 |
Role of ethanol-induced sodium overload in atrial fibrillation |
| P560 |
Inflammatory cell infiltration in left atrial appendageal tissues of patients with atrial fibrillation and sinus rhythm |
| P561 |
Cryoballoon-based Pulmonary Vein Isolation in Obese versus Normal Weight Patients: Notable Differences, Data from a Single Center Registry |
| P562 |
Schnellere Echtzeit-Pulmonalvenenisolation mittels Viertgenerations-Cryoballon bei Patienten mit Vorhofflimmern |
| P563 |
Second and fourth generation Cryoballoon based left atrial appendage isolation for the treatment of persistent atrial fibrillation |
| P564 |
Wide-band dielectric imaging, the novel Cryoballoon-Occlusion tool and 3D transesophageal echocardiography to guide Cryoballoon-based pulmonary vein isolation |
| P565 |
Heart rate variability and its influence on recurrence of atrial fibrillation after cryoballoon or radiofrequency ablation |
| P566 |
Radiofrequency catheter ablation for redo procedures after pulmonary vein isolation with the cryoballoon technique: 4-year follow-up |
| P567 |
Analysis of cryoballoon pulmonary vein isolation-mediated sinus rate increase in patients with paroxysmal atrial fibrillation |
| P568 |
Radiofrequency or cryoballoon ablation for index pulmonary vein isolation: What is the impact on long-term clinical outcomes after repeat ablation? |
| P569 |
Efficacy and Complications of Cavo-tricuspid Isthmus Dependent Atrial Flutter Ablation in Patients with and without Structural Heart Disease: Results from the German Ablation Registry |
| P570 |
Prevalence of supraventricular arrhythmias following orthotopic heart transplantation in a large cohort |
| P571 |
Predicting the type of paroxysmal supraventricular tachycardia based on symptoms: implications of gender and age and development of a logistic regression model in a contemporary patient cohort |
| P572 |
Rapid left atrial appendage thrombus formation after cessation of oral anticoagulation in patients with previous electrical isolation of the left atrial appendage |
| P573 |
Echocardiographic Strain Imaging of Atrial Contractility Identifies Presence of Left Atrial Low-voltage Substrate and Thrombi in Patients with Atrial Fibrillation |
| P574 |
Feasibility, efficacy and safety of zero fluoroscopy catheter ablation for atrioventricular nodal reentrant tachycardia in 111 consecutive patients |
| P575 |
Spatial relationship between ablation sites within the pulmonary trunk and the left coronaries: Systematic risk assessment based on three-dimensional reconstruction of cross sectional imaging |
| P576 |
A Case of Pleomorphic Ventricular Contractions originating from the Mitral Annular Disjunction |
| V578 |
In failure prone hearts, epigenetic priming of cardiac progenitor cells shifts from endothelial to adipocyte differentiation: Role of a novel network involving STAT3, tenascin C, PGD2 and Zfp423 |
| V579 |
Knockout of purinergic receptor Y13 (P2Y13) results in an improved outcome in metabolic syndrome in mice |
| V580 |
Acylcarnitines switch substrate utilization from glucose to fatty acids by selectively inhibiting pyruvate-dependent respiration in cardiac mitochondria |
| V581 |
Isoproterenol regulates cardiac cardiolipin content and mitochondrial function |
| V590 |
Single cell sequencing reveals novel insights into endothelial plasticity after myocardial infarction |
| V591 |
Die PI3-Kinase d schützt durch Kontrolle regulatorischer CD4+ T-Zell-Funktionen vor Arteriosklerose |
| V592 |
Myocardial infarction triggers inflammatory deterioration of vascular niche by accelerating loss of a specific vessel subtype in bone |
| V593 |
Empagliflozin impairs smooth muscle cell proliferation, accelerates endothelial regeneration, and prevents neointima formation by altered expression of the vasoactive peptide apelin |
| V606 |
Non-invasive ECG-Imaging for Identification of Atrial Arrhythmogenic Low Voltage Substrate in Patients with Persistent Atrial Fibrillation |
| V607 |
Impact of diabetes mellitus and glucose intolerance on outcome after PVI with cryo-balloon |
| V608 |
Catheter ablation for atrial fibrillation with heart failure with preserved ejection fraction |
| V609 |
Cardiac magnetic resonance imaging derived left ventricular mechanical function in patients with atrial fibrillation and left atrial low voltage zones |
| V611 |
Cardiac Magnetic Resonance Myocardial Feature Tracking for Optimized Risk Assessment after Acute Myocardial Infarction in Patients with Type 2 Diabetes |
| V612 |
Fast-SENC intramyocardial LV & RV strain detects cardiac dysfunction of symptomatic patients before ejection fraction (LVEF/RVEF) |
| V613 |
Global longitudinal strain predicts outcome in chronic heart failure across heart failure phenotypes: Results from the MyoVasc Study |
| V614 |
Global and segmental longitudinal strain imaging and quantification of myocardial fibrosis in patients with acute myocarditis and preserved systolic left ventricular function |
| V615 |
Late Gadolinium Enhancement as a Predictor of Adverse Events in Patients with Hypertrophic Cardiomyopathy – 12-Year Outcome Data |
| V616 |
Prognostic value of global longitudinal strain versus mitral annular plane systolic excursion in patients with ischemic heart failure |
| V617 |
Therapietreue, kardiovaskuläre Ereignisse und Therapiekosten unter der Single Pill Ramipril/Atorvastatin/ASS im Vergleich zur Gabe der identischen Einzelkomponenten – Ergebnisse der START-Studie |
| V618 |
Impact of statin therapy intensity on circulating endothelial progenitor cells in patients undergoing percutaneous coronary intervention |
| V619 |
Markers for cholesterol metabolism and cardiovascular outcomes in patients with chronic kidney disease |
| V620 |
Prevalence of hypertriglyceridemia in statin treated high risk patients who might benefit from treatment with icosapent ethyl for secondary prevention in clinical practice – Results of DYSIS |
| V621 |
Effektivität der kardiologischen Rehabilitation auf die Adhärenz zur lipid-senkenden Therapie bei 1.100 Patienten mit Koronarer Herzerkrankung: Das LLT-R-Register |
| V622 |
How a new ESC/EAS Guidelines for management of dyslipidaemias 2019 influenced the amount of healthy individuals in working population with low risk SCORE <1 who should be eligible for statin therapy |
| V628 |
Congenital-Cardio-Cloud – proof of feasibility and challenges of e-Cardiology in Germany |
| V629 |
Reviewing Cyber Security Research of Implantable Medical Rhythm Devices regarding Patients’ Risk |
| V630 |
Welche Unterschiede erwarten Patienten und deren Angehörige in ihrer Interaktion mit Ärzten und mit eHealth-Lösungen? – Ergebnisse einer Interviewstudie im Projekt PASSION-HF |
| V631 |
Long-term Outcomes in Heart Failure Predicted By Machine Learning on Monophasic Action Potentials |
| V632 |
Novel high-resolution and wireless continuous Smart ECG Monitoring improves arrhythmia detection and reveals subtle cardiac autonomic modulation changes acompanying postoperative atrial fibrillation |
| V633 |
Use of artificial intelligence to process ECG data for identification of heart failure – a meta-analysis |
| V634 |
Long-term Follow-Up of patients with Catecholaminergic polymorphic ventricular arrhythmia |
| V635 |
Long-term follow-up of implantable cardioverter-defibrillators in Short QT syndrome in a multicenter study |
| V636 |
Implantable cardioverter-defibrillator in Brugada syndrome: long-term follow-up |
| V637 |
Eligibility for subcutaneous implantable cardioverter-defibrillator in Adult Congenital Heart Disease patients |
| V638 |
Impact of implantable cardioverter-defibrillators on mortality among grown-up patients with congenital heart disease (GUCH) awaiting heart transplantation – Data from the Eurotransplant Registry |
| V639 |
Long-term follow-up of patients with peripartum cardiomyopathy and an implantable cardioverter defibrillator – a multicenter study |
| V640 |
Distinct mechanism and acute ablation success of atrial tachycardias assessed by high density mapping systems – a single-center analysis |
| V641 |
Prospective Validation of a Novel Algorithm for High Resolution Mapping Facilitating Critical Isthmus Detection in Atrial Tachycardia |
| V642 |
The impact of HD mapping technology on arrhythmia-free survival after RF ablation of atypical atrial flutter |
| V643 |
Ablation of consecutive atrial tachycardias after ablation of persistent atrial fibrillation: Does high density mapping lead to better results ? |
| V644 |
First ablation procedures of atypical atrial flutter achieve a better outcome when compared to redo flutter ablation procedures |
| V645 |
Successful ablation of atypical atrial flutter by ethanol infusion into the Vein-of-Marshall network |
| V646 |
Integrative analyses of multi omics studies in calcific aortic valve disease |
| V647 |
Impact of myocardial fibrosis on LV remodeling, recovery and outcome after TAVI in different hemodynamic subtypes of severe aortic stenosis |
| V648 |
Aortic valve calcification’s impact on in-hospital complications and long term survival following TAVI |
| V649 |
Clonal hematopoiesis of indeterminate potential associates with pro-inflammatory circulating blood cell phenotypes and confers worse prognosis in patients with aortic valve stenosis undergoing TAVI |
| V650 |
Importance of secondary cardiac alterations for the progression of isolated moderate aortic valve stenosis |
| V651 |
Preserved Th2 lymphocytes improve prognosis of diabetic patients undergoing TAVR |
| V677 |
Inversion of the force-frequency relationship in failing human myocardium correlates with the degree of t-system remodeling |
| V678 |
AAV9-mediated delivery of an NFAT-neutralizing decoy oligonucleotide ameliorates heart failure in mice |
| V679 |
Impact of Siah2 on cardiomyocytes and fibroblasts in adaptation to RV failure |
| V680 |
CITED4 Deficiency Leads to Accelerated Heart Failure in Pressure Overload Induced Cardiac Injury |
| V681 |
Saraf-dependent activation of mTORC1 regulates pathological cardiac growth |
| V682 |
Transgenic inhibition of calpain allows for nuclear export of calcineurin and regression of hypertrophy |
| V683 |
Long non-coding RNA H19 suppresses cardiac hypertrophy through an epigenetic mechanism involving PRC2 |
| V684 |
Highly selective D2 receptor stimulation rescues heart function in PPCM mice |
| V685 |
Inhibition von extrazellulärem Cyclophilin A vermindert Angiotensin II-vermittelte myokardiale Hypertrophie |
| V686 |
Impact of risk factors for atherosclerosis in cancer patients, a retrospective cohort study |
| V687 |
Welche Patienten profitieren von Telemedizin? – Analyse von Vorhofflimmern und Herzinsuffizienz in der TIM-HF2 Studie |
| V688 |
Long- and short-term mortality of Dresden Impella Registry – LV unloading improved outcome compared to predicted mortality |
| V689 |
Serotonin levels in NET patients are related to cardiac biomarkers and function |
| V691 |
Is training combined with genetic predisposition for high exercise capacity protective against pressure overload induced heart failure? |
| V692 |
Skeletal muscle iron deficiency leads to muscle atrophy and exercise intolerance |
| V693 |
Impact of Isometric Handgrip Exercise on Cardiac Strain in Subjects with and Without Heart Failure |
| V694 |
Excessive exercise is associated with increased global cardiac fibrosis |
| V695 |
Improving Prognostication of Neurologic Outcome with Measurement of Gray-White-Matter-Ratio in CCTs of comatose Patients after Cardiac Arrest |
| V696 |
Kreatinin ist ein Biomarker für das Versterben nach primär erfolgreicher kardiopulmonaler Reanimation |
| V697 |
Influence of implantation access on complication rates in ICD implantation |
| V698 |
Prevalence of frailty, comorbidity, and other geriatric conditions in an elderly patient cohort presenting with ACS |
| V699 |
Patient-Reported Outcome Measures (PROMs) bei Transkatheter-Aortenklappenersatz (TAVI) Patienten als quantitativer Daten-Input in einer TAVI-Scorecard |
| V700 |
Der Wunsch nach Sicherheit durch digitale Medizin – Ergebnisse einer Interviewstudie mit Herzinsuffizienz-Patient*innen und ihren Angehörigen im Projekt PASSION-HF |
| V701 |
Das Selbstvertrauen zu steigern, um sich mehr zutrauen zu können – eine Herausforderung der kardiologischen Ausbildung |
| V702 |
Prognostic Value of Coronary CT Angiography-derived Plaque Features and Clinical Parameter on Adverse Outcome Using Support Vector Machine Learning |
| V703 |
Aktivierung kardialer Fibroblasten als Hinweis auf kardiovaskuläre Risikofaktoren und pathologische Umbauprozesse |
| P815 |
Impaired left atrial compliance following left atrial appendage occlusion- implications for global left atrial function in sinus rhythm or atrial fibrillation |
| P816 |
Comparing Echocardiography In Stroke – Background, Aims, and Results of the CEIS Study |
| P817 |
Echocardiographic reference values of the aortic root – Results from the Hamburg City Health Study |
| P818 |
Epicardial adipose tissue differentiates patients with and without coronary microvascular dysfunction |
| P819 |
Extensive cardiac infiltration and subsequent right-sided heart failure in a patient with pre T-cell acute lymphoblastic leukaemia |
| P820 |
Vergleich der anatomischen Regurgitationsfläche mit konventionellen Verfahren zur Bestimmung der effektiven Regurgitationsfläche bei der Quantifizierung der funktionellen Mitralklappeninsuffizienz |
| P821 |
Implications of the new grading scale: Mortality of patients with isolated severe, massive, and torrential tricuspid regurgitation |
| P822 |
Noninvasive assessment of coronary artery morphology and function in young adults after neonatal arterial switch operation for TGA – a cardiac MRI study and follow-up recommendations |
| P823 |
Von Willebrand Factor as long-term prognostic factor in adult congenital heart disease |
| P824 |
Adults over the age of 40 years with complete atrioventricular septal defects are burdened with significant morbidity and mortality |
| P825 |
MicroRNA 150-5p is a predictor of overt heart failure in adolescent and adult patients with univentricular hearts |
| P826 |
Effects of Age on Action Potential Shape in Right Ventricular Myectomies of Paediatric Tetralogy of Fallot Patients |
| P827 |
Ablation of Reentry Tachycardia in Congenital Heart Disease: Use of High-Density-Mapping and a novel electrogram “Lumipoint” algorithm for critical isthmus detection |
| P828 |
Acute Coronary Syndrome Due to Single Coronary Artery: Clinical Implications For Diagnostic Work-Up And Therapy |
| P829 |
Troponin and natriuretic peptide in the monitoring of cancer therapy-induced cardiotoxicity |
| P830 |
Right ventricular function and mechanics in patients with melanoma undergoing immune checkpoint inhibitor therapy |
| P831 |
Chemotherapy-free combination of venetoclax, dasatinib and dexamethasone cures BCR-ABL+ acute lymphoblastic leukemia and prevents leukemia-induced cardiac damage |
| P832 |
Representation of cancer patients and cancer mortality in trials of heart failure with reduced ejection fraction |
| P833 |
Correlation of quantitative 99m-Tc-DPD-SPECT/CT with echocardiographic parameters in cardiac transthyretin amyloidosis |
| P834 |
Reversible myocardial oedema due to acute myocardial infarction as differential diagnosis of cardiac transthyretin amyloidosis |
| P835 |
Segmental left and right ventricular Fast-SENC strain quantifies cardiac dysfunction irrespective of ejection fraction in amyloidosis patients |
| P836 |
Predictors of cellular cardiac rejections at follow-up after heart transplantation |
| P837 |
Can shear wave imaging replace right heart catheterization in the follow up of heart transplant recipients? |
| P838 |
Five-year results of heart rate control in patients after heart transplantation receiving either ivabradine or metoprolol succinate |
| P839 |
Bestimmung der relativen T2 Ratio mittels CMR bei der Tako-Tsubo-Kardiomyoptahie (TCM) und Korrelation zur Wandbewegung, CKMB, TRT, LVEF und EKG-Veränderungen |
| P840 |
Association between Mortality and Left Ventricular Ejection Fraction in patients with Takotsubo Syndrome versus Acute Coronary Syndrome |
| P841 |
Short- and long – term outcome after cardiogenic shock in Takotsubo syndrome and acute coronary syndrome |
| P842 |
Prevalence, management and outcome of adverse rhythm disorders in Takotsubo Syndrome: Insights from the international multicenter GEIST registry |
| P843 |
Treatment of Cardiomyopathies in Germany: Data from the Prospective DZHK TORCH Registry |
| P844 |
High Incidence of Mental Disorders in Patients with Peripartum Cardiomyopathy |
| P845 |
Improvement of Psychological Wellbeing after ICD-Implantation: Gender-related Differences – Results from the Anxiety-CHF Study |
| P846 |
Association between Socioeconomic Status and Mortality/Morbidity in Heart Failure: An Analysis from the Swedish Heart Failure Registry |
| P847 |
Hospitalisierung wegen Herzinsuffizienz: auch 30 Jahre nach dem Mauerfall deutliche Unterschiede zwischen Ost und West |
| P848 |
Angst-, Depressionsscores und Lebensqualität nach Implantation eines Linksventrikulären Assist Devices (LVAD) |
| P849 |
Einfluss von Musik während der transösophagealen Untersuchung auf Kurznarkotikadosis und Sedierungstiefe: Das Alster Beat Register |
| P850 |
Platelets are a major source of Proproteinkonvertase Subtilisin/Kexin Typ 9 (PCSK9) mediating thrombosis and inflammation |
| P851 |
Targeting the Chemokine Receptor CXCR7 Favours An Anti-thrombotic Lipidome over Pro-thrombotic Lipids to Regulate Platelet Functions |
| P852 |
CXCR4 / CXCL14 interaction mediates platelet function and migration |
| P853 |
Annexin A7 is a critical regulator of Ca2+ mobilization and lipid metabolism during platelet activation and arterial thrombosis |
| P854 |
Effekte von Edoxaban und Warfarin auf vaskuläres Remodelling: Atherosklerotische Plaqueprogression und Kollateralarterienwachstum |
| P855 |
Rivaroxaban reduziert die arterielle Thrombose durch Inhibition von FXa induzierter Plättchenaktivierung via Protease Activated Receptor-1 |
| P856 |
Vitamin K epoxide reductase complex subunit 1 like 1 inhibition promotes vascular inflammation by modulating endoplasmic reticulum stress in human coronary artery smooth muscle cells |
| P857 |
Activation of the sphingosine-1-phosphate receptor 1 (S1PR1) enhances ADP-induced platelet reactivity |
| P858 |
Angiogenesebildgebung mittels Ga-68-NODAGA-RGD Positronen-Emissions-Tomographie (PET) als Prädiktor für das Ausmaß linksventrikulären Remodelings im Mausmodell nach kardialer Stammzelltherapie |
| P859 |
Characterization of acute and long-term cardiac damage and dysfunction following thoracic irradiation |
| P860 |
The heat shock protein A4 averts pathological myocardial remodeling possibly through improvement of protein quality control |
| P861 |
The role of the Rac1 activator Tiam1 in cardiac stress remodeling |
| P862 |
The Effect of Brain Natriuretic Peptide (BNP) on diastolic force adaptation to cardiac stress: In-vitro Assessment in Human Myocardium |
| P863 |
Cardiac myosin specific T cells acquire a regulatory phenotype in the heart and modulate collagen deposition after experimental myocardial infarction |
| P864 |
Suppressed local hepcidin expression induces cardiac iron deficiency after myocardial infarction |
| P865 |
LEA29Y expression in pigs facilitates acceptance of regenerative human tissue |
| P866 |
Genetic compensation prevents myopathy and heart failure in an in vivo model of Bag3 deficiency |
| P867 |
The hydrogen-peroxide producing NADPH oxidase 4 limits restenosis development after vascular injury in mice |
| P868 |
P2X7 dependent inflammasome activation is crucial for scar integrity after myocardial infarction |
| P869 |
Impact of left and right heart failure on skeletal muscle in a novel two-stage model in rats |
| P870 |
Blockade of the innate immune checkpoint CD47 decreases infarct size by modulation of oxidative stress and immune response |
| P871 |
Decoding dilated cardiomyopathy with ataxia syndrome (DCMA) with patient and genetically modified human iPSC- derived cardiomyocytes |
| P872 |
Comparative analysis of RBM20-mutation based LVNC and DCM using a patient-specific stem cell system |
| P873 |
Catabolic activation and mitochondrial dysfunction contribute to impaired diaphragm function in patients with severe heart failure – results from the LIPAMUS-HF study |
| P874 |
Detection of parvovirus B19 NS1 and VP1/2 mRNAs as markers for transcriptional viral activity in endomyocardial biopsy-based diagnosis of patients with unexplained heart failure |
| P875 |
Metoprolol treatment during the onset of arrhythmogenic cardiomyopathy showed no beneficial effects in heart specific Desmoglein 2 knock-out mice |
| P876 |
Treatment of cardiac fibrosis with anti-proliferative small molecules |
| P877 |
Bildgebung der myokardialen Inflammation im Herzinfarktmodell der Maus mittels F-18-FDG PET als prognostische Methode zur Abschätzung des Therapieffektes nach kardialer Stammzelltherapie |
| P878 |
Genetic background, age, sex, and pacing cycle length affect left atrial electrophysiology in Langendorff-perfused isolated murine hearts |
| P879 |
Can Hypocalcaemia Cause Severe Sinus Bradycardia and Asystole in Dialysis Patients? |
| P880 |
Perivascular Excitation Tunnelling in Ischaemia-Reperfusion |
| P881 |
Safe electrophysiologic profile of dexmedetomidine in an experimental whole-heart model |
| P882 |
Purinergic receptor Y6 (P2Y6) deficiency impairs left ventricular function |
| P883 |
The role of the secreted modular calcium binding protein 1 in the resolution of inflammation |
| P884 |
CLEC4E plays an essential role in human artherogenesis |
| P885 |
Clonal hematopoiesis in patients with chronic ischemic heart failure: identification of cut-off variant allele frequencies for DNMT3A- and TET2-driver gene mutations for assessing long-term prognosis |
| P886 |
Hyaluronan Synthase 3 controls post-ischemic vessel growth through endothelial NO signaling |
| P887 |
Blood plasma exosomes: isolation and incubation with cells of the cardiovascular system |
| P888 |
BMPER affects vascular smooth muscle cell phenotype switching and vascular remodelling |
| P889 |
Subluminal accumulation of diabetic CD 14++ monocytes is driven by an impaired reverse migration |
| P890 |
The alternation of connexin expression in endothelial cells through mechanical and inflammatory stimulation |
| P891 |
New aspects of the Eph/ephrin system in vascular smooth muscle cells (VSMC) |
| P892 |
Mononuclear cells release extracellular inflammasome complexes that induce pro-inflammatory signaling in endothelial cells |
| P893 |
Transient inhibition of translation during reperfusion increases long-term cardiac function after myocardial infarction |
| P894 |
NR4A1 as a therapeutic target in experimental Takotsubo Syndrome |
| P895 |
Macrophage-specific IRF5 deficiency stabilizes atherosclerotic plaques in ApoE-/- mice |
| P896 |
Normofrequent atrial fibrillation deteriorates human ventricular function |
| P897 |
The role of CaMKII and Calcineurin in Takotsubo Syndrome |
| P898 |
Resolving the impact of differential Junctophilin-2 clustering, loss-of-function, and therapeutic rescue in an atrial hypertrophy model |
| P899 |
Radiation Exposure in Monoplane versus Biplane Percutaneous Coronary Interventions: The RAMBO Trial |
| P900 |
Basophils balance healing after myocardial infarction via IL-4/IL-13 |
| P901 |
Loss of CTRP9 impairs cardiac glucose uptake and cardiac function in mice suffering from diabetic cardiomyopathy |
| P902 |
Catheter Ablation of Atrial Fibrillation in Heart Failure with Preserved Ejection Fraction – Interim Analysis of the AFFECT Study |
| P903 |
Exercise training in patients with a left ventricular assist device (Ex-VAD): baseline data of a multicentre, prospective, assessor-blinded, randomized, controlled trial |
| P904 |
Infektiöse Endokarditis und bakterielle Biofilme – Etablierung eines in vitro-Modells zur Evaluation therapeutischer und präventiver Device Coatings |
| P905 |
Deficiency of Macrophage-miR-147 exacerbates Atherosclerosis in Mice |
| P906 |
Learned helplessness induces endoplasmic reticulum stress in the heart of mice |
| V908 |
Reduced expression of collagenases in the infarcted heart is beneficial for the outcome after myocardial infarction |
| V909 |
Protection by ischemic preconditioning involves a non-neuronal cardiomyocyte-based cholinergic system |
| V910 |
ADAM10 inhibition improves survival and preserves cardiac function after myocardial infarction |
| V911 |
The Programmed Death 1 immune checkpoint protects the heart from ischemia/reperfusion injury |
| V912 |
Immunomodulation, remodeling and myofibroblast transdifferentiation – emerging roles of foxo3a in myocardial infarction |
| V913 |
Agrin attenuates adverse remodeling after myocardial infarction in a pig model |
| V922 |
Selective optogenetic stimulation of fibroblasts to quantify their electrical influence on cardiomyocytes in a 3 dimensional model of heart tissue |
| V923 |
Ventrikuläre Dysfunktion, atriale Überleitungsstörungen und Vorhofflimmern in JDP2-überexprimierenden Mäusen |
| V924 |
Electro-mechanical and mechano-electrical interactions in healthy and drug-induced LQTS rabbit hearts |
| V925 |
Electrophysiological mechanisms of tachycardia-induced cardiomyopathy |
| V937 |
The risk of pulmonary-valve-related infective endocarditis after percutaneous and surgical pulmonary valve implantation in patients with congenital heart disease |
| V938 |
Evaluation der Prävalenz schlafbezogener Atmungsstörungen, obstruktiver Ventilationsstörungen und des Overlap-Syndroms bei Erwachsenen mit angeborenen Herzfehlern |
| V939 |
Pulmonary arterial hypertension associated with congenital heart disease leads to significant morbidity and mortality in adults over the age of 40 years |
| V940 |
Depression predicts mortality and quality of life in adult congenital heart disease |
| V941 |
Clinical Characteristics and Outcomes of Adults with Congenital Heart Disease listed for Heart Transplantation in the Eurotransplant Region |
| V942 |
Prevalence and impact of overt heart failure on outcome in patients with complex congenital heart disease |
| V943 |
Heart Failure with recovered Ejection Fraction (HFrecEF): a new entity with improved cardiac outcome |
| V944 |
Determinants and prognostic implication of improved left ventricular ejection fraction in chronic heart failure patients with reduced ejection fraction |
| V945 |
Registry data with long term follow up of hospitalized patients with chronic heart failure |
| V946 |
Assessment of medication adherence in patients with acute decompensated heart failure – a two-centre prospective study |
| V947 |
Pharmacist/physician care improves quality of life in elderly heart failure patients: results of the PHARM-CHF randomized controlled trial |
| V948 |
Sex-specific differences drive temporal trends and outcomes of patients hospitalized for heart failure in Germany |
| V953 |
Left ventricular dysfunction in patients receiving immune checkpoint inhibitor therapy |
| V954 |
Establishing of a clinical workflow to diagnose immune checkpoint inhibitor induced myocarditis |
| V955 |
Global longitudinal strain reduction correlates with immune-related adverse events in patients with melanoma treated with immune checkpoint inhibitors |
| V956 |
Diagnostic and therapeutic pathways in a cardio-oncology center – one year experience |
| V957 |
Association of IDH1/2 mutations in established AML with risk of coronary artery disease and cardiac dysfunction |
| V958 |
Surgical amputation of the left atrial appendage as concomitant procedure for stroke prevention in patients with atrial fibrillation undergoing heart surgery |
| V959 |
Relevant correlation of Galectin-3 with a novel morphological classification system for LAA closure – the end of echocardiographic follow up after occluder implantation? |
| V960 |
Initial and long-term antithrombotic therapy after left atrial appendage closure with the WATCHMAN |
| V961 |
A Collective European Experience with Left Atrial Appendage Suture Ligation using the LARIAT+Device |
| V962 |
Percutaneous Left Atrial Appendage Closure using a novel LAmbre occluder in patients with atrial fibrillation, updated procedural and clinical results from FAFA institutional registry study |
| V963 |
WATCHMAN Versus ACP or Amulet for Left Atrial Appendage closure – Results From the LAARGE Registry |
| V964 |
Auswirkungen von Multi Point Pacing und SyncAV auf die elektrische Dyssynchronie bei Patienten mit kardialer Resynchronisationstherapie (CRT) |
| V965 |
Measures to improve biventricular pacing in Cardiac Resynchronization Therapy – what does really help? Insights from single center real-life data |
| V966 |
Very Long-Term Follow-Up of electrocardiographic parameters in cardiac resynchronization therapy: wider paced QRS, worse prognosis? |
| V967 |
Leadless endocardial pacing improves symptoms in patients with failed conventional CRT implant in long term follow up |
| V968 |
Transvenous lead extraction in patients with cardiac resynchronization therapy (CRT) devices – Outcome & Risk prediction: A GALLERY subgroup analysis |
| V969 |
Pacemaker vs. defibrillator therapy in patients eligible for cardiac resynchronisation therapy: evidence from the German Device Registry |
| V970 |
Intentional leaflet laceration to prevent coronary obstruction during TAVI: First systematic single-center European experience with the BASILICA technique |
| V971 |
Access site complication in transfemoral transcatheter aortic valve implantation |
| V972 |
Transfemoral and transapical transcatheter aortic valve implantation for pure non-calcified native aortic valve regurgitation |
| V973 |
Impact of on-clopidogrel platelet reactivity on incidence of peri-interventional bleeding in patients undergoing transcatheter aortic valve implantation |
| V974 |
Dynamics of Cerebral Oxygenation During Transfemoral Transcatheter Aortic Valve Implantation and Its Impact on Outcome |
| V975 |
Bioprosthetic valve fracture can be safely performed to reduce the residual gradient and correct preexisting prothesis-patient-mismatch |
| V976 |
Efficacy of the Orsiro sirolimus-eluting stent in small vessel coronary artery disease |
| V977 |
Angiographic results from the randomized BASKET-SMALL 2 trial – Drug-coated balloon versus drug-eluting stent in small coronary artery lesions |
| V978 |
Ten-year Clinical Outcomes From A Randomized Trial Of Polymer-free Sirolimus- And Probucol-eluting Stents Versus Permanent Polymer Zotarolimus-eluting Stents In Patients With Coronary Artery Disease |
| V979 |
Angiographic Evaluation of the Antirestenotic Performance of Everolimus-eluting Stents in the Setting of In-stent Restenosis |
| V980 |
Absence of an increased risk of death after coronary paclitaxel coated balloons: systematic review and meta-analysis of randomized trials |
| V981 |
Impact of successful recanalization of chronic right coronary artery occlusion (RCA-CTO) on right ventricular function |
| V982 |
Impact of Right Atrial Physiology on Heart Failure and Adverse Events after Myocardial Infarction |
| V983 |
Frequency and Prognostic Impact of Right Ventricular Involvement in Acute Myocardial Infarction |
| V984 |
Clinical Outcomes of Transcatheter Tricuspid Valve Repair in Heart Failure with Preserved and Reduced Ejection Fraction |
| V998 |
Reversing endothelial cell aging by partial reprogramming |
| V999 |
Cystathionine-?-lyase regulates retinal angiogenesis via sulfhydration of metabolic proteins |
| V1000 |
The role of the RNA Splicing factor HRSP1 in Angiogenesis |
| V1001 |
The endothelial angiotensin type 1 receptor/Akt1 axis is the mechanistic link to vascular remodeling during hypertension |
| V1002 |
Extracellular vesicles (EVs)-transmitted long noncoding RNA GAS5 is dysregulated in patient with coronary artery disease (CAD) and regulates recipient endothelial cell function |
| V1003 |
Non-coding RNA-dependent addressing of the chromatin remodelling complex BRG1 determines endothelial phenotypic specification |
| V1004 |
Adventitial macrophages invade the atherosclerotic plaque |
| V1005 |
Cytochrome P450 reductase prevents cardiac hypertrophy through endothelial cell crosstalk |
| V1006 |
Permanent atrial fibrillation is associated to increased platelet derived extracellular vesicles in the left atrial appendage |
| V1007 |
Treatment strategies and outcome in patients with device-related thrombus – Results of the multi-center EUROC-DRT registry |
| V1008 |
How important is impedance for radiofrequency ablation? Insights on its influence on ablation lesions and clinical RF application |
| V1009 |
Randomised controlled trial to define the optimum target interlesion distance in ablation index-guided atrial fibrillation ablation |
| V1010 |
Comparative Analysis of the Prognostic Impact of Different Types of Ventricular Tachyarrhythmias |
| V1011 |
Inflammatory responses may contribute to arrhythmogenesis of Brugada syndrome |
| V1012 |
Mapping and ablation of polymorphic ventricular tachyarrhythmia in patients without identifiable structural heart disease: genetic findings and origin of triggers |
| V1013 |
Electrocardiographic signs of right ventricular hypertrophy comparing desmoglein-2 and plakophilin-2 mutations in arrhythmogenic cardiomyopathy |
| V1014 |
Immune cells and chemokine expression during the onset of arrhythmogenic cardiomyopathy – studies in Desmoglein 2 mutant mice |
| V1015 |
Fatal ventricular arrhythmias are controlled by OCaR2 proteins, a new regulator of cardiomyocyte Ca2+ signaling at the lysosomal-SR junction |
| V1016 |
The role of TMEM43 in the pathogenesis of arrhythmogenic cardiomyopathy in zebrafish |
| V1017 |
Antiarrhythmic Effects of Disopyramide and Vernakalant in Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes from a Patient with Short QT Syndrome Type 1 |
| V1018 |
CNP is Anti-Arrhythmic In-Vivo by Activating PDE2 |
| V1019 |
Epicardial access for VT ablation: Analysis of two different puncture techniques, incidence of adhesions and complication management |
| V1020 |
Sex-specific incidence, treatment and outcome in patients with acute coronary syndrome |
| V1021 |
Performance of the ESC 0/1h and ESC 0/3h algorithm in patients with anaemia and suspected acute myocardial infarction |
| V1022 |
Early left ventricular thrombus formation after ST-elevation myocardial infarction: a prospective observational CMR study |
| V1031 |
GIP prevents cardiac remodeling in murine heart failure and predicts a favourable prognosis in patients with acute myocardial infarction |
| V1032 |
Role of selective insulin resistance in endothelial dysfunction |
| V1033 |
PPAR-gamma activation inhibits in vivo degeneration of bioprosthetic valves under diabetic conditions |
| V1034 |
Deregulation of thioredoxin system contributes to monocyte dysfunction in diabetes mellitus: Implications for impaired arteriogenesis in type2 diabetic patients |
| V1035 |
Acute hyperglycaemia protects the diabetic heart in an in vivo model of heart failure |
| V1036 |
GLP-1 verbessert die linkventrikuläre Funktion im Mausmodell der kardialen Hypertrophie unabhängig vom GLP-1 Rezeptor und dem Glukosemetabolismus |
| V1049 |
Overexpression of the Na+/K+-ATPase a2-isoform attenuates adverse cardiac remodeling and ß1-adrenoceptor downregulation after chronic myocardial infarction injury |
| V1050 |
Inhibition of transient outward potassium current Ito by oxidation-activated protein kinase A type I contributes to early afterdepolarizations |
| V1051 |
Treatment with calcium sensitizer Levosimendan accelerates heart failure while the combination of Bromocriptine and Levosimendan prevents heart failure in an experimental mouse model of PPCM |
| V1052 |
Calmodulin controls mitochondrial calcium uptake in cardiac mitochondria |
| V1053 |
Long-term effects of empagliflozin on cardiomyocyte excitation-contraction-coupling |
| V1054 |
Exploring the Role of the Stretch-Activated Channel Piezo1 in AF-Related Cardiac Remodelling |
| V1059 |
Serum sphingosine 1-phosphate as a marker for coronary artery disease severity – Results from the INTERCATH cohort |
| V1060 |
Changes in micro-RNA secretion patterns following anti-CD3 treatment regulate the expression of adherens junctions in PBMCs |
| V1061 |
Risk modification and Mortality in patients with high platelet response to Adenosine-diphosphate (ADP) in the LURIC study |
| V1062 |
Cardiac Troponin I and Incident Stroke in European Cohorts – Insights from the BiomarCaRE Project |
| V1064 |
Reduced cardiovascular endpoints through Sodium-glucose cotransporter 2-inhibitors (SGLT2i) in patients with type 2 diabetes mellitus. The comparative efficacy of individual SGLT2i remains unclear |
| V1065 |
Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and PKG oxidation |
| V1066 |
Acute Effects of Empagliflozin on Hemodynamic Parameters in Patients with Type 2 Diabetes |
| V1067 |
Genetic variation in sodium-glucose cotransporter 2 and heart failure |
| V1068 |
Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for mortality in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials |
| V1069 |
Assessment of causality of natriuretic peptides and atrial fibrillation and heart failure – A Mendelian randomization study in the FINRISK cohort |
| V1070 |
The Impact of Time from Diagnosis at Baseline on Long-Term Outcome in the GRIPHON Study: Selexipag in Pulmonary Arterial Hypertension (PAH) |
| V1071 |
Long-term safety and outcome of subcutaneous and intravenous treprostinil treatment in patients with severe chronic pulmonary hypertension |
| V1072 |
Mid-term outcomes of patients with intermediate-high or high risk pulmonary embolism treated with percutaneous ultrasound-assisted catheter-directed thrombolysis |
| V1073 |
Safety and feasibility of percutaneous ultrasound-assisted catheter-directed thrombolysis in patients with intermediate-high or high risk pulmonary embolism |
| V1074 |
Beneficial effects of ferric carboxymaltose in patients with pulmonary arterial hypertension and iron deficiency: A long-term study |
| V1075 |
The impact of balloon pulmonary angioplasty on leucocyte subset distribution in circulating blood from patients with chronic thromboembolic pulmonary hypertension (CTEPH) |
| V1077 |
Drug Treatment of Type 2 Diabetes Mellitus Patients with an Incident Cardiovascular Comorbidity: An analysis based on a large German claims dataset |
| V1078 |
Quantifying awareness of heart failure of the lay public: Derivation and validation of a Heart Failure Awareness Score |
| V1079 |
Going beyond the surface – A multidimensional approach to documenting and analyzing adverse events |
| V1080 |
Venous Thromboembolism in Patients with Endoprosthetic Hip Joint Replacement Surgery |
| V1081 |
Atrial fibrillation detection in a pharmacy-based mass-screening – Results of an 8-week Follow-Up |
| V1082 |
Specialized management of oral anticoagulation therapy improves outcome in patients with chronic renal insufficiency |
| V1083 |
Trigger factors for appropriate ICD shocks and its prognostic implications |
| V1084 |
Prognostic Impact of Coronary Chronic Total Occlusion on Recurrences of Ventricular Tachyarrhythmias in ICD Recipients |
| V1085 |
Management of ICD patients after first appropriate ICD shock: the three-step ToVAMI treatment concept |
| V1086 |
Management of inappropriate S-ICD shocks: to convert or not to convert? |
| V1087 |
Effectiveness of catheter ablation in long-term suppression of inappropriate ICD therapies due to rapidly conducted atrial arrhythmias |
| V1088 |
Reduction of inadequate S-ICD shocks with the 2nd regeneration S-ICD – real-world data from a large single center registry |
| V1089 |
Ablation index guided high power pulmonary vein isolation for atrial fibrillation: updated data from the FAFA AI High Power Study |
| V1090 |
Similar rate of thermal esophageal lesions are found in patients alternatively assigned to high power short duration (70W, 8s) vs. lesion index guided (35W) ablation for atrial fibrillation |
| V1091 |
AF Ablation using Ablation index- risk or benefit for the esophagus? |
| V1092 |
Are automated automated algorithms able to identify critical zones of complex atrial tachycardia? |
| V1093 |
Posterior wall substrate modification using ablation index and inter-lesion distance measurement in patients with atrial fibrillation |
| V1094 |
Esophagus endoscopy after catheter ablation of atrial fibrillation using ablation index guided high power pulmonary vein isolation: The AI High-Power ESO Study |
| V1095 |
Durability of early generation transcatheter aortic valves: five-year results from the randomized CHOICE trial |
| V1096 |
Predictors of paravalvular regurgitation after transfemoral transcatheter aortic valve implantation according to valve type: data from the randomized SOLVE-TAVI trial |
| V1097 |
Incidence, feasibility and early outcome of redo transcatheter aortic valve implantation for structural and non-structural transcatheter valve dysfunction |
| V1098 |
Preliminary experience with a novel dry-storage pericardial aortic valve designed to optimize future valve-in-valve treatment |
| V1099 |
First single-center experience with the transcatheter LOTUS Edge™ Aortic Valve System after relaunch |
| V1100 |
Single center experience with the novel self-expanding ALLEGRA (NVT) transcatheter heart valve |
| V1101 |
Predicting factors for long-term survival in patients with out-of-hospital cardiac arrest – a propensity score-matched analysis |
| V1102 |
Stellenwert der Akut-Koronarangiographie nach prähospitaler Reanimation bei vermutetem NSTE-ACS – Erfahrungen aus einem Krankenhaus der Regelversorgung |
| V1103 |
Computer-Tomographie als Baustein der intensivmedizinischen Versorgung von Patienten nach extrahospitaler Reanimation – Erfahrungsbericht aus dem HACORE- Register |
| V1104 |
Neurological Outcome in patients with Out-of-Hospital Cardiac Arrest presenting without ST-Elevation as compared to ST-Elevation- Experience from the Hannover Cooling Registry (HACORE) |
| V1105 |
Elimination of Cytokines in Patients with Out-of-Hospital Cardiac Arrest Undergoing a Standardised Protocol Including Therapeutic Hypothermia – Experience from the HAnnover COoling REgistry (HACORE) |
| V1106 |
Systemic therapeutic hypothermia adjunctive to percutaneous coronary intervention in patients with acute myocardial infarction. A meta-analysis of randomized trials |
| V1125 |
Cardiac macrophages: a concentrate of voltage and stretch-activated channels |
| V1126 |
Endothelial BMP4 contributes to the systemic inflammatory response after survived cardiac arrest |
| V1127 |
The lncRNA Heat4 regulates the immune receptor locus IRL in heart failure |
| V1128 |
Thrombin receptor PAR4 drives sterile inflammatory signaling in the heart |
| V1129 |
Targeting PGE2 to treat sepsis-induced acute heart failure |
| V1130 |
GPR15-mediated early immune cell recruitment is essential for viral elimination in CVB3-induced myocarditis |
| V1131 |
Spsb1 is involved in inflammation-induced muscle atrophy |
| V1132 |
LXR Activation Enhances oxLDL-Induced Trained Innate Immunity in Human Monocytes |
| V1133 |
Trained Innate Immunity in Human Aortic Endothelial Cells Augments Monocyte Adhesion and Transmigration |
| V1134 |
First experience with automated left atrial appendage sizing based on a patient-specific 3D heart model in real-time |
| V1135 |
Quantification of organic mitral regurgitation by echocardiographic 3D proximal isovelocity surface area (3D-PISA): study validation with cardiovascular magnetic resonance |
| V1136 |
Computed tomography derived predictors of permanent pacemaker implantation after transcatheter aortic valve implantation: a meta-analysis |
| V1137 |
CT assessment of coronary obstruction risk in patients referred for transcatheter valve-in-valve aortic valve replacement |
| V1138 |
Computed tomographic assessment of the annulus dimensions for optimal transcatheter aortic valve prosthesis sizing – incidence and relevance of subannular clefts |
| V1139 |
Real-time Cardiac Magnetic Resonance T1 and Extracellular Volume Fraction mapping for Tissue Characterisation in Aortic Stenosis |
| V1140 |
FT-IR-Spektroskopie zur Darstellung der Pathogenese der Aortenklappenstenose und Aortenklappenprothesendegeneration |
| V1141 |
Interplay between left ventricular reverse remodelling assessed by T2 mapping and medium-term clinical outcomes after transcatheter aortic valve implantation |
| V1142 |
Impact of T2 mapping on development and persistence of conduction disorders after transcatheter aortic valve implantation |
| V1143 |
Early onset of menopause is associated with increased peripheral atherosclerotic plaque volume and progression – a risk factor unique to women |
| V1144 |
Pericoronary adipose tissue CT attenuation and its association with serum levels of atherosclerosis-relevant inflammatory mediators and MACE |
| V1145 |
Chronic colitis promotes atherogenesis and –progression: – unravelling the impact of neutrophils |
| V1146 |
Loss of the coronary artery disease gene SVEP1 promotes vascular inflammation and atherosclerotic plaque formation |
| V1147 |
The immune cell repertoire in human atherosclerotic plaques characterized by single cell RNA-sequencing and multi-color flow cytometry |
| V1148 |
Adipocyte-derived C1q/TNF-related protein (CTRP) 3 as a regulator of obesity and atherogenesis |
| V1149 |
Absence of arginase-1 in red blood cells modulates atherosclerosis and vascular calcification in mice |
| V1150 |
Colchicine prevents progression of atherosclerosis through reduction of plaque inflammation |
| V1151 |
Effekte körperlicher Aktivität auf pro-atherogene Monozytensubpopulationen |
| V1152 |
CMR strain imaging: age associated arterial stiffness and heart rate influence systolic and late diastolic myocardial strain rate |
| V1153 |
Functional and Prognostic Implications of Cardiac Magnetic Resonance Feature Tracking derived Remote Myocardial Strain Analyses in Patients following Acute Myocardial Infarction |
| V1154 |
Longitudinal strain in patients with severe aortic regurgitation: Sensitivity vs. ejection fraction for myocardial dysfunction |
| V1155 |
Global Longitudinal Strain by Feature Tracking for Optimized Prediction of Adverse Remodeling after ST-Elevation Myocardial Infarction |
| V1156 |
Chronic coronary syndromes lead to reduced strain parameters compared to patients without myocardial ischemia in a propensity score-matched cohort assessed by cardiac magnetic resonance imaging |
| V1157 |
Analysis of left ventricular rotational deformation by 2D speckle tracking – a feasibility analysis in healthy volunteers |
| V1158 |
Head to Head Comparison of Cardiovascular Magnetic Resonance Feature Tracking Cine vs. Acquisition based Deformation Strain Imaging using Myocardial Tagging and Strain Encoding |
| V1159 |
Influence of reconstruction parameters on the accuracy of CT derived strain: comparison with echocardiography |
| P1160 |
Real world use of cerebral protection in patients undergoing transfemoral transcatheter aortic valve replacement |
| P1161 |
Temporal trends in cerebrovascular events following TAVI |
| P1162 |
Stroke after transcatheter aortic valve implantation: an unpredictable risk? |
| P1163 |
Stroke patterns after TAVI |
| P1164 |
Ventricular Pacing in Patients with New Left Bundle Branch Block and New Atrioventricular Block I post TAVI |
| P1165 |
Prolongation of the His-ventricular interval following transcatheter aortic valve replacement |
| P1166 |
Conduction disturbance following transcatheter aortic valve implantation: differences between prosthesis related to valve calcifications |
| P1167 |
Predictors of permanent pacemaker implantation in patients receiving a balloon-expandable transcatheter aortic valve prosthesis – an international multicentre analysis |
| P1168 |
Cerebral embolization in TAVI: Is there a difference between balloon-expandable and self-expanding transcatheter heart valves? |
| P1169 |
Impact of Tricuspid Regurgitation on TAVR Patient Outcome |
| P1170 |
Baseline concomitant mitral regurgitation predicts outcome in aortic stenosis patients undergoing aortic valve replacement |
| P1171 |
Assessment of left ventricular stroke volume in patients with severe aortic stenosis |
| P1172 |
Low-Gradient Aortic Stenosis in Patients With Normal Left Ventricular Ejection Fraction Undergoing Transcatheter Aortic Valve Implantation |
| P1173 |
Left Ventricular Mechanical Dispersion in Flow-Gradient Patterns of Severe Aortic Stenosis |
| P1174 |
Fundamental prognostic role of the mean transvalvular gradient in patients with aortic stenosis and heart failure after transcatheter aortic valve implantation |
| P1175 |
TAVI for low flow low gradient aortic stenosis: Prognostic impact of aortic valve calcification |
| P1176 |
Early Hemodynamic Changes after Transcatheter Aortic Valve Implantation Measured by Invasive Pressure Volume Loop Analysis |
| P1177 |
Left trial appendage thrombosis in patients with severe aortic stenosis treated by transfemoral transcatheter aortic valve implantation |
| P1178 |
Impact of frailty and nutritional status on mortality in patients with severe aortic valve stenosis undergoing percutaneous transcatheter aortic valve implantation |
| P1179 |
Safety and Efficiency in treating patients 90 years and older with symptomatic severe aortic valve stenosis by transfemoral aortic valve replacement (TAVR) |
| P1180 |
Low incidence of cardiac TTR-amyloidosis in a consecutive cohort of patient with symptomatic degenerative high-grade aortic stenosis |
| P1181 |
Depression and anxiety in elderly patients with severe symptomatic aortic stenosis: prevalence, prognostic relevance and dynamics after transcatheter aortic valve implantation (TAVI) |
| P1182 |
Presence of depression significantly compromises quality of life in patients with aortic stenosis irrespective of cardiac damage |
| P1183 |
Improvement of depression following Transcatheter Aortic Valve Implantation (TAVI) is accompanied by a significant decrease in serum levels of C domain containing Tenascin-C (C+Tn-C) |
| P1184 |
Impact of combined “CHADS-BLED” score to predict short-term outcomes in transfemoral and transapical aortic valve replacement |
| P1185 |
Impact of right and left ventricular dysfunction on long-term outcome of moderate to severe secondary mitral regurgitation patients without surgical/interventional treatment |
| P1186 |
Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor outcome in patients undergoing transcatheter mitral valve repair with the MitraClip |
| P1187 |
Comparison of different phenotypes of postcapillary pulmonary hypertension in heart failure patients undergoing transcatheter mitral valve repair for severe mitral regurgitation |
| P1188 |
Favourable long-term outcomes for patients with intermediate-failure phenotype heart failure: a simple patient selection tool for MitraClip therapy in patients with secondary mitral regurgitation |
| P1189 |
Characterization of patients with right heart dysfunction undergoing transcatheter mitral valve repair for severe mitral regurgitation |
| P1190 |
Impact of Tricuspid Regurgitation and its Postprocedural Reduction on Long-Term Outcome in Patients Undergoing Percutaneous Mitral Valve Edge-to-Edge Repair |
| P1191 |
MitraClip for severe mitral regurgitation also reduces tricuspid regurgitation – is tricuspid clip necessary? |
| P1192 |
Frailty predicts mortality in patients with severe mitral – or tricuspid valve regurgitation |
| P1193 |
Multidimensional prognostic index (MPI) predicts 6-months-mortality in patients undergoing transcatheter edge-to-edge mitral valve repair with MitraClip |
| P1194 |
Association of QRS duration with outcomes after transcatheter mitral valve repair |
| P1195 |
Prognostic value of mitral valve tenting area in patients with functional mitral regurgitation |
| P1196 |
Reduced preoperative LVEF and MAPSE serve as independent determinants of worse outcome in moderate to severe mitral regurgitation patients undergoing mitral valve repair |
| P1197 |
Improvement of cognitive function in patients with heart failure following interventional mitral valve repair |
| P1198 |
Impact of the extent of reduction of mitral regurgitation on long-term prognosis after MitraClip® in a large monocentric cohort |
| P1199 |
Improvement of left atrial function in patients with mitral regurgitation undergoing percutaneous mitral valve repair, as obtained by 2D strain echocardiography at 6M follow-up |
| P1200 |
Myocardial fibrosis and left ventricular re-remodeling after novel mitral valve repair for functional mitral regurgitation |
| P1201 |
Non-linear relationship between CMR Fast-SENC segmental intramyocardial strain and ejection fraction in evaluating progression of myocarditis |
| P1202 |
MiRNA profiling as a novel diagnostic tool for identification of patients with inflammatory and/or virally induced cardiomyopathies |
| P1203 |
Rapid and severe remodeling of the transverse tubular system induced by acute viral myocarditis |
| P1204 |
Mechanisms of angina in patients with biopsy-proven viral myocarditis: Insights from intracoronary acetylcholine testing |
| P1205 |
High sensitive Troponin T as gatekeeper for cardiac magnetic resonance imaging in patients with suspected acute myocarditis |
| P1206 |
Transcriptional active parvovirus B19 infection and intramyocardial inflammation predict adverse long-term mortality in a large cohort of patients with non-ischemic cardiomyopathy |
| P1207 |
Feasibility, safety and efficacy of transradial left ventricular endomyocardial biopsy |
| P1208 |
Cardiac magnetic resonance features in biopsy-proven myocarditis compared to biopsy-proven dilated cardiomyopathy |
| P1209 |
Impact of Morphine Treatment with and without Metoclopramide Co-Administration on Myocardial and Microvascular Injury in Acute Myocardial Infarction |
| P1210 |
Development and validation of a score for early discrimination of patients with myocardial infarction type I and type II |
| P1211 |
Einfluss durch die Auswahl des GRACE risk scores auf Therapieentscheidungen anhand von Leitlinienempfehlungen |
| P1212 |
Standardized risk-adjusted management after cardiac catheterization for non-ST-elevation myocardial infarction – associations with in-hospital clinical outcomes |
| P1213 |
Gender differences in acute myocardial infarction |
|
– a German nationwide real-life analysis |
| P1214 |
Contemporary data on ventricular septal defects after myocardial infarction – bad prognosis, even worse for women |
| P1215 |
Gender differences in Management and Outcome in Elderly ACS Patients |
| P1216 |
Prevalence and causes of myocardial infarction with non-obstructive coronary arteries (MINOCA) in a contemporary cohort of patients with suspected myocardial infarction |
| P1217 |
Externe Verlegungen aus peripheren Krankenhäusern vs. direkte Aufnahmen im PCI-Zentrum bei Patienten mit ST-Hebungsinfarkt |
| P1218 |
Changes of Incidence and Outcome of ST-elevation Myocardial Infarction |
| P1219 |
Temporal Trends in In-Hospital Complications of Acute Coronary Syndromes |
| P1220 |
Der multimorbide Patient mit akutem Herzinfarkt: Was hat sich über 12 Jahre geändert? Daten des Berlin-Brandenburger Herzinfarktregisters |
| P1221 |
Entwicklung der 1- und 5-Jahres-Prognose zwischen 2006 und 2018 bei Patienten nach unkompliziertem ST-Hebungsinfarkt und erfolgreicher perkutaner Koronarintervention |
| P1222 |
Influence on culprit lesion location and TIMI flow after PCI on outcome after PCI for acute myocardial infarction complicated by cardiogenic shock. Results of the ALKK-PCI Registry |
| P1223 |
Prognostische Bedeutung des prä-hospitalen EKG bei reanimierten STEMI-Patienten – Ergebnisse aus FITT-STEMI |
| P1224 |
Is comorbidity and frailty an indicator for treatment and outcome in elderly patients with acute coronary syndrome? |
| P1225 |
Diagnostic Capacity of MR-proANP in Systolic Heart Failure assessed by Echocardiography |
| P1226 |
Limited value of ST2 to detect systolic heart failure compared to NT-proBNP |
| P1227 |
Limited role for fibroblast growth factor 23 (FGF23) in assessing prognosis in heart failure patients: Data from the TIME-CHF trial |
| P1228 |
Cysteine-rich angiogenic inducer 61 (Cyr61, CCN1) in serum is associated with left ventricular remodeling |
| P1229 |
Diagnostic Value of ST2 in Right Heart Failure |
| P1230 |
MR-proANP reflects Right Ventricular Function assessed by Echocardiography |
| P1231 |
MR-proADM reflects Right Ventricular Function assessed by Echocardiography |
| P1232 |
Non-invasive measurement of zinc protoporphyrin for detection of iron deficiency in heart failure |
| P1233 |
Outcomes of Endovascular Treatment for Infrapopliteal Peripheral Artery Disease Based on the Updated TASC II Classification |
| P1234 |
Early neurological outcome in aortic surgery |
| P1235 |
Impact of High on-treatment Platelet Reactivity after Angioplasty in Patients with Peripheral Arterial Disease |
| P1236 |
Intravascular lithotripsy in calcified, femoropopliteal and crural lesions: real-world single-center experience |
| P1237 |
Alcohol-Mediated Renal Denervation Using the Peregrine System Infusion Catheter for Treatment of Hypertension |
| P1238 |
Renal Denervation Modifies Aortic Distensibility and Hemodynamic Detoriations in Patients with Heart Failure and Preserved Ejection Fraction |
| P1239 |
Left ventricular longitudinal strain in professional athletes: a useful tool to detect an athlete’s hearts |
| P1240 |
Effect of supervised training in severe pulmonary arterial hypertension and inoperable or persistent chronic thromboembolic pulmonary hypertension on pulmonary arterial compliance and stroke volume |
| P1241 |
Non-invasive assessment of central hemodynamic parameters and right ventricular- arterial coupling in elite indoor athletes |
| P1242 |
Bedeutung der kardiopulmonalen Leistungsfähigkeit für die diastolische Funktion im Alter |
| P1243 |
Lower Handgrip Strength is Associated with a Smaller and Stiffer Heart in the General Population. The Study of Health in Pomerania (SHIP) |
| P1244 |
Exercise capacity in patients implanted with left ventricular assist devices for end-stage heart failure treatment |
| P1245 |
Drug adherence and characteristics of patients presenting with hypertensive urgency at an emergency room |
| P1246 |
Efficacy and safety of selexipag in pulmonary arterial hypertension (PAH) patients with and without significant cardiovascular (CV) comorbidities |
| P1247 |
Survival Outcome Analysis in Patients with Intermediate High-Risk Pulmonary Embolism in a Tertiary Referral Hospital – A Propensity Score Analysis |
| P1248 |
Der oral bioverfügbare p110a selektive PI3K Inhibitor BYL719 inhibiert RTK-vermittelte Zellantworten in PASMCs und schützt vor Hypoxie-induzierter PH |
| P1249 |
Humanes rekombinantes Relaxin-2 schützt vor Hypoxie-induzierter PH bei Mäusen |
| P1250 |
Tumor-associated thrombosis and the impact of the activated coagulation factor X (FXa) |
| P1251 |
Die unerwartete Rolle der PI3-Kinase ? in pulmonaler Hypertonie |
| P1252 |
Stellenwert der F-18-FDG-PET/CT im Rahmen der Endokarditis-Diagnostik – retrospektive Singlecenter-Analyse bei Patienten mit operativ gesicherter infektiöser Endokarditis |
| P1253 |
Diagnostische Herausforderungen bei infektiöser Endokarditis – ist das PET/CT die Lösung? |
| V1255 |
miR-181a: novel Aldosterone-Mineralocorticoid Receptor pathway regulator |
| V1256 |
Impact of endothelial cell mineralocorticoid receptors on left ventricular remodeling, gene expression and chromatin accessibility after pressure overload |
| V1257 |
The dimer interface of ERK1/2 provides a cardio-safe strategy to inhibit pathological ERK signaling |
| V1258 |
Impact of sphingosine-1-phosphate signaling on phenotypic alterations of vascular smooth muscle cells in the development of aortic aneurysms |
| V1259 |
RGS3L increases the cardiac contractility through a M2 muscarinic acetylcholine receptor induced RhoA activation |
| V1260 |
The novel cardiac kinases ELCK1 and ELCK2 regulate phosphorylation of the essential myosin light chain in the heart |
| V1276 |
Isolated pulmonary embolism is associated with a high risk of arterial thrombotic disease – Results from the VTEval Study |
| V1277 |
An optimised high sensitivity troponin I cut-off value for risk stratification in normotensive patients with pulmonary embolism |
| V1278 |
Outcome prediction in high-risk pulmonary embolism |
| V1279 |
Defining tachycarida by a heart rate =100 beats per minute for risk stratification of normotensive patients with pulmonary embolism |
| V1280 |
Patientencharakterisierung und Therapieansprechen einer positiven Vasoreaktivitätstestung bei pulmonal arterieller Hypertonie: Hämodynamik, Behandlungsmuster und klinische Parameter |
| V1281 |
Case Fatality Rates and Use of Systemic Thrombolysis in Pregnant Women with Pulmonary Embolism. Data from the German Nationwide Registry |
| V1291 |
Repeat ablation in patients with durable pulmonary vein isolation: impact of left atrial low voltage areas on atrial arrhythmia recurrence |
| V1292 |
High density mapping catheters may detect connections of pulmonary veins to the left atrium in 3 out of 4 patients that are missed by conventional circular mapping catheters. |
| V1293 |
Left Atrial Isolation: a new strategy for the advanced left atrial disease |
| V1294 |
Effect of Pulmonary Vein Isolation on Prevalence of Rotational Activation During Atrial Fibrillation |
| V1295 |
High anatomical accuracy of a novel high-resolution wide-band dielectric imaging system in pulmonary vein isolation |
| V1296 |
Arrhythmia recurrence despite permanent complete PV isolation: Results of ultra-high density mapping and reablation |
| V1301 |
Transcatheter mitral valve repair of functional mitral regurgitation – An updated meta-analysis |
| V1302 |
Ventricular Cardiac Power Indices to predict mortality after successful percutaneous edge-to-edge repair for severe mitral valve regurgitation |
| V1303 |
Changes in NT-proBNP Predict Outcome in Patients undergoing Transcatheter Edge-to-Edge Tricuspid Valve Repair |
| V1304 |
Instrumental activities of daily living (IADL) and its prognostic relevance in patients undergoing percutaneous mitral valve repair |
| V1305 |
Impact of indentations and cleft-like indentations on procedural outcome in percutaneous edge-to-edge mitral valve repair |
| V1306 |
Implications of pulmonary disorders on two-year outcome after percutaneous repair of mitral regurgitation with the MitraClip |
| V1307 |
Incidence of Cardiogenic Shock and Use of Mechanical Circulatory Support in Germany between 2005 and 2016 |
| V1308 |
Kardiogener Schock und Alter bei Patienten mit ST- Hebungsinfarkt – Charakteristik, Präsentation und hospitaler Verlauf. Ergebnisse des PCI-Registers der Arbeitsgemeinschaft leitender Krankenhausärzte |
| V1309 |
Kardiogener Schock und Zugang über die A. radialis bei Patienten mit ST- Hebungsinfarkt – Prävalenz, Charakteristik und hospitaler Verlauf. Ergebnisse des PCI-Registers der ALKK |
| V1310 |
Use, efficacy and safety of GP IIb/IIIa inhibitors and P2Y12-Inhibitors in patients undergoing PCI for acute myocardial infarction complicated by cardiogenic shock. Results of the ALKK-PCI Registry |
| V1311 |
Hemodynamic and metabolic changes due to left ventricular unloading by Impella® Heart pump in patients suffering from cardiogenic shock within 24 h – results from the Jenamacs- Impella registry |
| V1312 |
Procedure Volume and Outcomes in Patients with VA-ECMO |
| V1332 |
Proarrhythmic interaction of NaV1.8 and Ca2+/Calmodulin dependent protein-kinase II as an antiarrhythmic target in heart failure |
| V1333 |
Fibroblasts control angiogenesis via the SASP factor PAI-1 in the aging mouse heart |
| V1334 |
Investigations regarding the role of NOS1AP in the heart using a conditional overexpression mouse model |
| V1335 |
p38 MAPKa is a key regulator of cardiac glucose metabolism for adapting to pressure overload |
| V1336 |
Supra-, intra- and infra-annular transcatheter heart valves for the treatment of aortic stenosis in patients with a small aortic annulus – a large multicenter analysis |
| V1337 |
Cyclodextrin reduces aortic valve stenosis development in mice |
| V1338 |
Safety and efficacy of protamine administration for the prevention of bleeding complications in patients undergoing transcatheter aortic valve implantation |
| V1339 |
Long-term TEE follow-up after percutaneous left atrial appendage closure |
| V1341 |
LXR activation influences cardiac lipid formation and reduces damage in an isoproterenol induced cardiomyopathy model |
| V1342 |
The lipid-droplet-associated protein ABHD5 protects the heart through proteolysis of HDAC4 |
| V1343 |
Platelet lipidomics play a pivotal role in lipid metabolism of patients with CAD and differ among disease and treatment. A perspective of translating biomolecule levels to clinical parameters |
| V1344 |
Impact of hepatocellular and cardiac lipids on myocardial energy metabolism |
| V1345 |
Localization of the femoral artery bifurcation: Hips don’t lie – in 99 % of cases |
| V1346 |
Characteristics of the prosthesis position after TAVI with the balloon-expandable SAPIEN 3 in patients with bicuspid aortic valves |
| V1347 |
Opportunistische CT-Bildgebung: Fettige Muskelfraktion zur Outcome-Prädiktion bei Patienten nach minimalinvasivem Aortenklappenersatz |
| V1348 |
Standardised comparison of aortic valve complex calcification in contrast enhanced versus native CT acquisitions in patients referred for transcatheter aortic valve implantation |
| V1349 |
CT assessment of regional left ventricular myocardial thickness as a marker of viability: a head-to-head comparison with cardiac magnetic resonance late gadolinium enhancement |
| V1350 |
Additional value of computed tomographic angiography based fractional flow reserve compared to standard computed tomographic angiography – a machine-learning algorithm in a real-world clinical setting |
| V1351 |
Sicherheitsprofil elektiv durchgeführter koronarer CT-Angiographien |
| V1352 |
Comparison of invasively measured FFR with FFR derived from coronary CT angiography for detection of lesion-specific ischemia in proximal and distal lesions |
| V1353 |
Prognostic Value of cCTA Derived Morphological and Functional Quantitative Plaque Markers Using Semi-Automated Plaque Software |
| V1354 |
The effects of nitro-oleic acid in a murine model of dilated cardiomyopathy |
| V1355 |
Gut microbiomes impact on cholesterol reducing property of Atorvastatin |
| V1356 |
EV-incorporated microRNA in calcific aortic valve disease |
| V1357 |
Inhibition of Nucleotide Diphosphate Kinases as a novel therapeutic approach in cardiovascular diseases |
| V1358 |
New insights in ß-adrenergic signaling in aortic valve diseases |
| V1359 |
Development and Evaluation of 3D-printed Phantoms for Interventional Planning and Training |
| V1382 |
Impact of Active Mechanical Circulatory Support Devices on outcome of Cardiogenic Shock Complicating Acute Myocardial Infarction – Results From The CULPRIT-SHOCK Trial |
| V1383 |
Eligibility for mechanical circulatory support devices in cardiogenic shock based on current randomised trials: Real world data from a large clinical cohort |
| V1384 |
Improving treatment of driveline infections after LVAD implantation |
| V1385 |
Impaired leg perfusion during percutaneous left ventricular assist support in patients with cardiogenic shock |
| V1387 |
Comparison of prognosis and outcome of HFrEF patients treated with LCZ696 according to age |
| V1388 |
Impact of Sacubitril/Valsartan on the long-term incidence of ventricular arrhythmias in chronic heart failure patients |
| V1389 |
Divergent electrophysiologic properties of sacubitril in different experimental models of acquired long QT syndrome |
| V1390 |
Clinical outcomes in Patients with Ischemic versus Non-Ischemic Cardiomyopathy after Angiotensin-Neprilysin Inhibition therapy |
| V1391 |
LCZ696® (Sacubitril/ Valsartan) improves cardiac function independent of autophagy regulation in a mouse model of transverse aortic banding |
| V1392 |
The ARNI Sacubitril/Valsartan improves diastolic dysfunction in a rat HFpEF model |
| V1400 |
Cryoballon ablation for persistent atrial fibrillation: Lessons from more than 10 years of experience and 1,190 consecutive patients |
| V1401 |
Individualisierte Kälteenergieabgabe mit dem Cryoballon zur Pulmonalvenenisolation bei Patienten mit symptomatischem Vorhofflimmern – Ist prozeduraler Erfolg gleich langfristiger klinischer Erfolg? |
| V1402 |
Cryoballoon pulmonary vein isolation in atrial fibrillation using different freeze protocols: The FAFA ICE 4 vs. 3 Propensity-matched study |
| V1403 |
Incidence and characteristics of pulmonary vein reconduction after second-generation cryoballoon-based pulmonary vein isolation: Impact of different ablation strategies |
| V1404 |
Prognostic value of periprocedural termination of persistent atrial fibrillation after cryo-PVI followed by biatrial ablation of rotational activity |
| V1405 |
Impact of posterior roof ablation on long term outcome after pulmonary vein isolation with cryo-balloon |
| V1406 |
Catheter ablation of ventricular tachycardia in patients with electrical storm: a single centre experience from the German Heart Centre Munich |
| V1407 |
Ventrikuläre Arrhythmien mit Ursprung am atrioventrikulären Anulus bei Patienten mit erhaltener rechts- und linksventrikulärer Pumpfunktion: MRT Untersuchung, Katheterablation und Nachbeobachtung |
| V1408 |
Hybrid mapping during catheter ablation of premature ventricular contractions – a novel algorithm to improve mapping accuracy |
| V1409 |
Local impedance characterizes tissue characteristics and lesion formation in patients with ventricular tachycardia |
| V1410 |
Myeloperoxidase correlates with extend of ventricular low voltage areas in Patients undergoing VT Ablation |
| V1411 |
The novel approach for bipolar catheter ablation of therapy refractory ventricular tachycardia: A feasibility report |
| V1412 |
Comparison of XTR versus NT device for percutaneous edge-to-edge mitral valve repair on procedural results and changes in annulus geometry: a 3D transesophageal echocardiography study |
| V1413 |
Transcatheter edge-to-spacer mitral valve repair and reduction of the mitral valve orifice area: initial experience and comparison to the edge-to-edge system |
| V1414 |
Initial multicenter experience with the novel PASCAL edge-to-edge mitral valve repair system |
| V1415 |
Series of Compassionate-Use Transcatheter Mitral Valve Replacement with Mid-term Follow-up |
| V1416 |
Single Center Early Experience Using the PASCAL System for Transcatheter Treatment of Mitral Regurgitation in 46 Consecutive Patients |
| V1417 |
Mitral annular dimension can predict optimal outcome in use of MitraClip NTR and XTR |
| V1426 |
Contrast-agent free evaluation of cardiomyopathies with T1 mapping and the new fast Strain-encoded (f-SENC) magnetic resonance imaging |
| V1427 |
Fast-SENC cardiac magnetic resonance derived myocardial strain differentiates between different forms of left ventricular hypertrophy |
| V1428 |
T1-Mapping zur Diagnose einer akuten Myokardits – Was bringen uns cut-off Werte? |
| V1429 |
The unfavorable Relation of Ventricular Conduction Delay, Dysfunction and Remodeling in isolated Left Bundle-Branch Block |
| V1430 |
Diagnostic value of myocardial strain analysis in patients with acute myocarditis. A cardiac magnetic resonance imaging study |
| V1431 |
CMR Substrate Guided Biopsy in Cardiac Sarcoidosis – Case Report |
| V1443 |
Decrypting the contribution to myocardial passive stiffness from titin vs other viscoelastic elements using a novel mouse model |
| V1444 |
Analysis of unconventional motor protein myosin 5b and its impact on cardiac function |
| V1445 |
Direct interaction of myosin binding protein c and troponin, which alters function and thin filament integrity by cTn mutants |
| V1446 |
Myocardial stiffness is differentially regulated through unfolded domain oxidation (UnDOx) of elastic titin enabling the fine tuning of passive force |
| V1447 |
Metabolomic fingerprinting in patients with heart failure and reduced skeletal muscle function: data from LC-MS and skeletal muscle biopsies |
| V1448 |
Cardiac tissue-restricted deletion of plakophilin 2 results in progressive biventricular cardiomyopathy |
| V1449 |
Fine-tuning cardiac IGF1 signalling to simultaneously promote cardiac health and longevity |
| V1450 |
Bioenergetic consequences of defective mitochondrial calcium uptake in Barth syndrome cardiomyopathy |
| V1451 |
Cardiac iron concentration in relation to systemic iron status and disease severity |
|
in patients with dilated cardiomyopathy |
| V1452 |
Veränderung von typischen Biomarkern sowie der Nierenfunktion nach 2 Jahren Therapie mit der oralen Chaperontherapie Migalastat bei Patienten mit Morbus Fabry |
| V1453 |
Diagnostic Capactiy of Copeptin in Systolic Heart Failure assessed by Echocardiography |
| V1454 |
Can heart failure be classified by left ventricular ejection fraction? A latent class analysis |
| V1455 |
Prognostic impact of left-sided heart failure phenotype and mitral regurgitation in transcatheter tricuspid valve repair |
| V1456 |
Elevated C reactive protein, increased cardiac troponin I and smoking are associated with inflammatory cardiomyopathy in patients with heart failure with reduced ejection fraction |
| V1457 |
Verlauf von hochsensitivem Troponin T und NT-proBNP bei Patienten mit akuter Herzinsuffizienz unter verschiedenen Therapieregimes |
| V1458 |
Hypertrophic remodeling of retinal vessels in congestive heart failure |
| V1459 |
Sex differences in patients with cardiogenic shock |
| V1460 |
Impact of pulmonary hypertension on right heart failure and survival after heart transplantation in a German multicenter registry |
| V1461 |
Diagnostic Value of Copeptin in Right Heart Failure |
| V1462 |
Analysis of potential hemodynamic biomarkers in experimental pulmonary hypertension and consecutive right heart failure using 4D phase contrast velocity mapping MRI |
| V1463 |
Genetic findings in patients with different forms of pulmonary hypertension |
| V1464 |
Transcriptomic profiling of human right ventricle in chronic thromboembolic pulmonary arterial hypertension |
| V1465 |
Lack of ED-A domain-containing fibronectin attenuates monocrotaline-induced pulmonary hypertension and right heart failure in mice |
| V1466 |
Cell type-specific role of mineralocorticoid receptors in macrophages and fibroblasts in pulmonary hypertension and right heart failure |
| V1467 |
Activated endothelial TGF-beta signaling via endothelin-1 promotes thrombus non-resolution: potential role for chronic thromboembolic pulmonary hypertension |
| V1468 |
Effect of exercise training on 6 minute walking distance in severe precapillary pulmonary hypertension – results from a European multicenter randomized controlled trial |
| V1469 |
Comparison of ultrasound guided, ultrasound assisted and “blind” pericardiocentesis |
| V1470 |
A novel echocardiographic-derived classification of implanted Watchman devices can accurately predict incomplete ostial closure and significant peri-device leaks |
| V1471 |
Transesophageal Echocardiography Might Underestimate Peri-Device Leak After Interventional Left Atrial Appendage Closure Using Amplatzer Cardiac Plug |
| V1472 |
Retrospektiver Vergleich der Full-cycle Ratio (RFR) und fraktionellen Flussreserve (FFR) einer Kohorte von Patienten mit koronarer Herzerkrankung |
| V1473 |
Association of optimal stent expansion with incidence of target lesion failure: An optical coherence tomography study |
| V1474 |
Mechanism of drug-eluting absorbable metal scaffold restenosis: A serial optical coherence tomography study |
| V1475 |
Different coronary plaque components and the risk of plaque rupture – does the mix make it? Insights from the OPTICO-ACS study program |
| V1476 |
Utilization of IVUS improves all-cause mortality in patients undergoing invasive coronary angiography |
| V1477 |
Reduction of contrast media in computed tomography for the planning of transcatheter aortic valve replacement |
| P1478 |
Periprocedural Safety and Long-term Efficacy of Left Atrial Appendage Closure alone versus Combined with Other Structural or Coronary Interventions |
| P1479 |
Late Clinical Outcomes of LAmbre versus Amplatzer Occluders for Left Atrial Appendage Closure |
| P1480 |
Dynamics of Galectin-3 serum levels after percutaneous occlusion of the left atrial appendage: a new surrogate parameter for successful LAA closure? |
| P1481 |
Incidence, Persistence and Clinical Relevance of iatrogenic atrial septal defects after percutaneous left atrial appendage closure |
| P1482 |
Caging of left atrial appendage thrombus by left atrial appendage closure |
| P1483 |
Welcher Fall wird kompliziert? – Prädiktoren für Komplikationen im Österreichischen Herzohrverschlussregister |
| P1484 |
Results from a real time dosimetry study during left atrial ablations performed with ultra-low dose radiation settings |
| P1485 |
Predictors and Clinical Impact of Bleeding Events after Left Atrial Appendage Closure in Patients with High Bleeding Risk or History of Bleeding |
| P1486 |
CHA2DS2-VASC Score predicts Coronary Artery Disease Progression and Mortality after Ventricular Arrhythmia in Patients with Implantable Cardioverter-Defibrillator |
| P1487 |
Atrial fibrillation in patients with arrhythmogenic right ventricular dysplasia: an overlooked association |
| P1488 |
Prospective multicentric validation of a novel AF prediction model – the AF score trial |
| P1489 |
Prevalence and time course of arrhythmia-induced cardiomyopathy in patients with newly diagnosed heart failure and concomitant tachyarrhythmia |
| P1490 |
Electrocardiogram changes in a long-term follow-up after heart transplantation |
| P1491 |
Coronary artery disease in patients undergoing catheter ablation of isthmus-dependent atrial flutter |
| P1492 |
QRS duration corrected for heart rate is associated with mortality in cardiac patients without bundle branch block |
| P1493 |
Association between bundle branch block and coronary artery status: Insights from the LIFE-Heart Study |
| P1494 |
Cardiovascular outcomes, bleeding risk and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: Data from the RE-LY trial |
| P1495 |
First real-world data about Edoxaban in patients with atrial fibrillation in Germany, Austria and Switzerland from ETNA-AF Europe study: Event rate remains low over all CHA2DS2-VASc risk categories |
| P1496 |
Nationwide follow-up survey on periprocedural anticoagulation management for atrial fibrillation ablation procedures |
| P1497 |
Use, adherence, efficacy and safety of apixaban in patients with non-valvular atrial fibrillation in real life in Germany. Results of the prospective Apixaban in atrial fibrillation (APAF) registry |
| P1498 |
Full 1-Year-Follow-Up data snapshot among anticoagulated patients treated with edoxaban in Germany, Austria and Switzerland – Data Snapshot results from ETNA-AF study according to body mass index |
| P1499 |
Efficacy and risk of therapy with the vitamin K antagonist Phenprocoumone compared to direct oral anticoagulants in catheter ablation of atrial fibrillation |
| P1500 |
One-year follow-up of elderly patients with AF: Data from the ETNA-AF registry with edoxaban in Germany, Austria and Switzerland |
| P1501 |
First 1-year follow-up data snapshot analysis of more than 5,200 patients treated with edoxaban in routine clinical practice in Germany, Austria and Switzerland (DACH): Data from the ETNA-AF registry |
| P1502 |
Detailed analysis of the relation between RF ablation settings and resulting lesion metrics |
| P1503 |
Left Atrial Substrate Modification in Persistent Atrial Fibrillation using very High Power Short Duration Ablation with 70watts compared to a Standard Ablation protocol |
| P1504 |
High Power RF Ablation With Fixed Short Duration Is Rapid, Efficient And Safe For PVI Associated With Lower Early Recurrence of Pulmonary Vein Conduction and Less Esophageal Temperature Rise |
| P1505 |
High Power Radiofrequency Ablation With adjusted Fixed Short Duration is Efficient And Safe for Ablation of Atrial Fibrillation |
| P1506 |
The use of a high power (50W), ablation index guided protocol for pulmonary vein isolation |
| P1507 |
Feasibility and Safety of High Power/Short Duration Ablation in Patients undergoing Persistent Atrial Fibrillation Ablation |
| P1508 |
Acute efficacy and safety of pulmonary vein isolation for atrial fibrillation in patients alternatively assigned to high power short duration (70W, 8s) vs. lesion index guided (35W) ablation |
| P1509 |
Temporal relationship between myocardial infarction and atrial fibrillation and their association with mortality – insights from the BiomarCaRE consortium |
| P1510 |
Coronary artery disease in patients with atrial fibrillation and heart failure with preserved ejection fraction – from vicious twins to vicious triplets? |
| P1511 |
Determinants of symptoms in patients with atrial fibrillation |
| P1512 |
New onset postoperative atrial fibrillation- Metabolic markers, cytokines and remodeling anticipating paroxysmal atrial fibrillation |
| P1513 |
Hochsensitives Troponin T als prognostischer Marker für Letalität, Schlaganfall und schwere Blutungen bei Patienten mit Vorhofflimmern in der Notaufnahme |
| P1514 |
Serum heat shock protein 70 is associated with cardioversion and recurrence of symptomatic recent onset atrial fibrillation |
| P1515 |
Antiarrhythmic effect of ranolazine in combination with selective NCX-inhibition in an experimental model of atrial fibrillation |
| P1516 |
Scientometric analysis of international research activities in atrial fibrillation |
| P1517 |
Assoziation von Early-Repolarization und aberranten Sehnenfäden bei Patienten mit linksventrikulärer Hypertrabekulierung/Noncompaction |
| P1518 |
Sex-differences in Short QT Syndrome: a multicenter study |
| P1519 |
Long-term follow-up of patients with short QT syndrome: a multicenter study |
| P1520 |
Value of electrophysiological study testing in patients with Short QT Syndrome |
| P1521 |
Type-differences in Short QT Syndrome in a multicentre study |
| P1522 |
Clinical profile and long-term follow-up of children with Brugada syndrome |
| P1523 |
ECG changes and their prognostic impact in patients with TakoTsubo syndrome |
| P1524 |
Continuous, transcutaneous carbon-dioxide monitoring in complex electrophysiological procedures in deep sedation – Is there a safer way to sleep? |
| P1525 |
Three-dimensional transesophageal echocardiography versus magnetic resonance imaging for pulmonary vein imaging prior to catheter ablation of atrial fibrillation: extended long-term follow-up |
| P1526 |
The challenge of predicting recurrence after atrial fibrillation ablation: validation of seven risk scores in a prospective and independent cohort |
| P1527 |
Clinical outcome and incidence of complete pulmonary vein isolation in patients with recurrence of atrial fibrillation after multiple catheter ablation |
| P1528 |
Improved retinal flow density in patients with atrial fibrillation following pulmonary vein isolation measured using optical coherence tomography angiography |
| P1529 |
Outcome after practical isthmus ablation of scar-related atrial tachycardia guided by high-density mapping |
| P1530 |
Safety of propofol for deep sedation administered by EP staff in patients undergoing left atrial ablation procedures |
| P1531 |
Right ventricular pacing is associated with progression of tricuspid regurgitation after 2 years |
| P1532 |
Single Center Real Life Experience with Rate Responsive Stimulation by an Intracardiac Leadless Pacemaker during Everyday Physical Patient Activity |
| P1533 |
Development of Ejection Fraction after implantation of a leadless pacemaker system Four years Follow-Up Data of a single center cohort |
| P1534 |
The “Mont Blanc” Map of the AV-Node and the His Bundle as a guidance for Permanent His Bundle Pacing |
| P1535 |
Cardiac contractility modulation in patients with atrial fibrillation: Safety, feasibility and long term performance |
| P1536 |
Improvement of ventilatory efficiency and reduction of exercise oscillatory ventilation by Cardiac Contractility Modulation during follow-up |
| P1537 |
Long term transvenous defibrillation lead survival in implantable cardioverter-defibrillators: a large real live analysis |
| P1538 |
Comprehensive analysis of pacemaker patients with and without abandoned leads undergoing transvenous lead extraction: A GALLERY subgroup analysis |
| P1539 |
Role of VT ablation in very elderly patients – is there a too late? |
| P1540 |
Prognostic Impact of Coronary Artery Disease in Electrical Storm |
| P1541 |
Inzidenz und zeitliches Auftreten von ventrikulären Arrhythmien nach LVAD-Implantation im LZ-Beobachtungszeitraum |
| P1542 |
Chronic Kidney Disease is associated with Increased Long-term Mortality in Patients Presenting with Electrical Storm |
| P1543 |
Anemia is associated with Increased Long-term Mortality in Patients Presenting with Ventricular Tachyarrhythmias and aborted Cardiac Arrest |
| P1544 |
Increasing Age is associated with Mortality in Patients Presenting with Ventricular Tachyarrhythmias |
| P1545 |
Prognostic Impact of In-Hospital versus Out-Of-Hospital Cardiac Arrest Survivors with Ventricular Tachyarrhythmias |
| P1546 |
Inadequate heart rate control begets sustained ventricular arrhythmias in a large cohort of women |
| P1547 |
Baroreflex-Activation-Therapy in advanced heart failure: Do Patients benefit from an additional device based therapy? |
| P1548 |
Baroreflex activation therapy in heart failure with reduced ejection fraction – a single centre experience |
| P1549 |
Subannular repair for functional mitral regurgitation type IIIb in patients with ischemic versus dilated cardiomyopathy |
| P1550 |
Surgical Repair of Anteroapical Left Ventricular Aneurysms guided by Cardiac Computed Tomography: Assessment of Aneurysm Volume and of Anticipated Residual Left Ventricular Volume |
| P1551 |
Less Invasive Ventricular Enhancement Technique with the Revivent TC™ System (Bioventrix) significantly improves LV function and strain in symptomatic HFrEF patients – a comparison to SVR and OMT |
| P1552 |
Proportion of patients eligible for cardiac contractility modulation – real-life data from a patient cohort of a single-centre heart failure clinic |
| P1553 |
Einsatzgebiete der Impella Mikroaxialpumpe – Hämodynamische Unterstützung im infarktbedingten kardiogenen Schock, bei primär reanimierten Patienten und bei „Protected PCI“ |
| P1554 |
Design, concept and first in vitro results of the percutaneous, pulsatile left ventricular assist device-PERKAT LV |
| P1555 |
Septal mitral annular systolic excursion but not global longitudinal strain predicts outcome in non-ischemic heart failure patients with reduced ejection fraction and mild diastolic dysfunction |
| P1556 |
Quantifizierung der septischen Kardiomyopathie anhand hämodynamischer Parameter: Validierung der Nachlast-bezogenen Herzleistung (ACP) |
| P1557 |
Ventricular deformation analysis in cardiac magnetic resonance imaging: Feature tracking a supplementary parameter to improve the risk stratification in patients with ischemic cardiomyopathy |
| P1558 |
Testing for Preclinical diastolic dysfunction can estimate disease development |
| P1559 |
Copeptin is Associated with Pronounced Stages of Heart Failure with Preserved Ejection Fraction |
| P1560 |
MR-proADM is Associated with Advanced Grades of Heart Failure with Preserved Ejection Fraction |
| P1561 |
MR-proANP is Associated with Heart Failure with Preserved Ejection Fraction assessed by Echocardiography |
| P1562 |
Der H2FPEF-Score korreliert signifikant mit NT-proBNP bei Patienten mit hypertropher Kardiomyopathie |
| P1563 |
Relaxin family peptide Receptor 1 (RXFP1) for heart failure gene therapy |
| P1564 |
Molecular characterization of TASK-1 inhibition reveals novel candidates for pharmacotherapy of AF |
| P1565 |
NADPH oxidase 4 mediates the protective effects of physical activity against obesity-induced vascular dysfunction |
| P1566 |
Organ-specific effects of inhibitors of Sterol-O-Acyl-Transferase-1 on mitochondrial respiration and cellular function |
| P1567 |
The protrombotic signature of reticulated platelets |
| V1671 |
Differential impact of chronic ischemic heart failure on circulating monocytes and T cells elucidated by single cell RNA-sequencing |
| V1672 |
Apolipoprotein C3 induces systemic inflammation by alternative inflammasome activation of the NLRP3 inflammasome |
| V1673 |
Response to homeostatic signalling and angiotensin II-induced inflammation differs in yolk-sac and bonemarrow derived arterial macrophages |
| V1674 |
GLP-1 analog (Liraglutide) treatment in experimental arterial hypertension exerts anti-inflammatory effects and regulates the plasma proteome |
| V1675 |
T cell-derived adenosine controls IL-6 production in the infarcted heart by Gq-mediated activation of cardiac stromal cells |
| V1676 |
Local sympathetic control of cardiac macrophages |
| V1685 |
Orai1 deletion in cardiomyocyte reveals its protective role in Angiotensin-II-induced pathological cardiac remodeling |
| V1686 |
RNA editing in the failing heart regulates formation of circular RNAs |
| V1687 |
MiR-21 in cardiac macrophages controls cardiac fibrosis and determines pressure overload-induced cardiac dysfunction |
| V1688 |
Type II protein arginine methyltransferases are required for cardiac integrity and metabolic adaptation to stress |
| V1700 |
Mechanical Circulatory Support in Refractory Cardiogenic Shock due to Influenza Virus Related Myocarditis |
| V1701 |
Therapie mit ECLS- und/oder Mikroaxialpumpe bei Patienten im kardiogenen und septischen Schock. Untersuchung zur Indikationsstellung und zum Outcome |
| V1702 |
Dezelerationskapazität als Prädiktor von intrahospitaler Mortalität und schwerwiegenden Rhythmusereignissen nach Myokardinfarkt |
| V1703 |
Periodic Repolarization Dynamics zur Risikostratifizierung bei kardialen Intensivpatienten |
| V1704 |
High CREST-Score associates with implementation of Mechanical Circulatory Support in Patients with Out of Hospital Cardiac Arrest |
| V1705 |
Incidence,Treatment and Outcome of Cardiogenic Shock Complicating ST-Elevation Myocardial Infarction in Real Life: A Prospective Registry Analysis from A High Volume-PCI Center |
| V1710 |
Diagnostic value of the novel CMR parameter “myocardial transit-time” (MyoTT) in different hypertrophic cardiomyopathies including cardiac amyloidosis |
| V1711 |
Prevalence and clinical characteristics of atrial fibrillation in patients with cardiac amyloidosis |
| V1712 |
Diagnostic value of CMR-based T1/T2-mapping compared to longitudinal strain analysis-based assessment of relative apical sparing in patients with cardiac amyloidosis |
| V1713 |
Inertia and malpractice in cardiac amyloidosis |
| V1714 |
Massive cardiac AL amyloidosis in the absence of monoclonal gammopathy |
| V1715 |
Apoptotic mediators and myocardial inflammation are common findings in endomyocardial biopsies of patients with cardiac amyloidosis |
| V1716 |
Efficacy, safety and durability of renal denervation in higher risk subgroups: The Global SYMPLICITY Registry |
| V1717 |
Empagliflozin in probable resistant hypertension: findings from EMPA-REG OUTCOME |
| V1718 |
Baroreflex activation therapy for resistant hypertension: results from long-term prospective ambulatory blood pressure registry |
| V1719 |
Therapietreue und Ereignisraten unter RAAS-Blocker-Kombinationen zur Behandlung der arteriellen Hypertonie als „Single Pill“ im Vergleich zu Gabe der individuellen Einzelkomponenten – die START-Studie |
| V1720 |
Effects of Catheter-Based Renal Denervation on Left Ventricular Function Assessed by Two-Dimensional Speckle Tracking Echocardiography |
| V1721 |
6 months follow up from a randomized comparison of ultrasound versus radiofrequency-based catheter ablation techniques in therapy resistant arterial hypertension (RADIOSOUND-HTN) |
| V1726 |
Acute hemoptysis after cryoballoon pulmonary vein isolation – a multicenter study |
| V1727 |
Delayed cardiac tamponades after invasive electrophysiological procedures |
| V1728 |
Uninterrupted direct oral anticoagulants and vitamin K antagonists during ablation for atrial fibrillation: an updated meta-analysis |
| V1729 |
Incidental endoscopic findings in the MADE-PVI trial: pre-procedural proton pump inhibition is associated with fewer peri-esophageal lesions after cryoballoon pulmonary vein isolation |
| V1730 |
Phrenic nerve injury in atrial fibrillation ablation using balloon catheters: Incidence, characteristics and time course of recovery |
| V1731 |
A rare case of postoperative pulmonary vein stenosis after coronary artery bypass graft surgery with concomitant surgical bipolar radiofrequency ablation of pulmonary veins |
| V1738 |
MitraClip XTR vs. PASCAL Transcatheter Valve Repair System for Edge-to-Edge Repair of Severe Tricuspid Regurgitation |
| V1739 |
One-Year Outcome of Transcatheter Repair of Tricuspid Regurgitation: Comparison Edge-to-Edge Repair versus Annuloplasty |
| V1740 |
Two-Year Outcomes of the TRI-REPAIR Study Assessing Cardioband Tricuspid Valve Reconstruction System for Patients with Severe Tricuspid Regurgitation |
| V1741 |
Renal function of patients with severe tricuspid regurgitation undergoing caval vein implantation of the Edwards Sapien XT valve |
| V1742 |
Impact of caval vein implantation of the Edwards Sapien XT valve on severity of tricuspid regurgitation, right heart function and morphology |
| V1743 |
Early single center experience with a novel transcatheter anuloplasty system for the treatment of functional tricuspid regurgitation |
| V1744 |
Real world prospective monocentric study to compare rotational atherectomy and novel lesion preparation tool „Intravascular Lithotripsy“ for the treatment of heavily calcified coronary lesion |
| V1745 |
Impact of Lesion Preparation Technique on Side Branch Compromise in Calcified Coronary Bifurcations: A Subgroup Analysis of the randomized PREPARE-CALC Trial |
| V1746 |
Treatment of moderate and severely calcified coronary lesions with intravascular lithotripsy vs. high pressure dilatation: A propensity- matched analysis of efficacy and safety |
| V1747 |
Intravascular lithotripsy for underexpanded undilatable stents in calcified coronary lesions |
| V1748 |
Predictors of in-hospital adverse outcomes during rotational atherectomy: The role of a target vessel SYNTAX score |
| V1749 |
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents after rotational atherectomy. A singel center observational study |
| V1768 |
Absence of Protein Tyrosine Phosphatase-1B in Smooth Muscle Cells Promotes Perivascular Fibrosis: Role of Kruppel-like factor 4 |
| V1769 |
Pharmacological activation of AMPK prevents aircraft noise induced oxidative stress, endothelial dysfunction and vascular inflammation |
| V1770 |
Modulation of vasodilation by betalain-enriched supplement and in comparison to therapeutically used organic nitrate: Circulating NOHb determination as a clinicaly relevant marker of bioavailable NO |
| V1771 |
Inhibition von extrazellulärem Cyclophilin A vermindert die Angiotensin II-vermittelte Entstehung von Aneurysmen |
| V1772 |
Sema3f inhibits angiogenesis and promotes progression of heart failure |
| V1773 |
Neutralizing interleukin-1ß prevents accumulation of inflammatory plaque leukocytes |
| V1774 |
PIKfyve inhibition reduces the calcification potential of vascular smooth muscle cell-derived extracellular vesicles |
| V1775 |
Myeloid cell derived Interleukin-6 results in vascular dysfunction in mice |
| V1776 |
Pharmacological blockade of ET receptor or activation of FOXO-3 transcription factor provide a new mechanistic insight into vascular and cerebrovascular damage in a mouse model of E-cigarette exposure |
| V1777 |
Optimized heart failure therapy under WCD protection is the goal for LV-EF Improvement |
| V1778 |
The Wearable Cardioverter-Defibrillator : experience in 153 patients and a long-term follow-up |
| V1779 |
Comparison of the outcome of patients treated with wearable Life-vest for <90 wear days versus =90 wear days |
| V1780 |
Versorgungsrealität in der Behandlung von Risikopatienten mit der tragbaren Defibrillator-Weste (WCD) – Vergleich der Jahre 2017 und 2018 |
| V1781 |
Head-to-head comparison of clinical outcomes in patients with subcutaneous ICD versus patients with transvenous one-chamber ICD |
| V1782 |
Real-world setting patient and implant procedure characteristics of the MicraTM transcatheter pacemaker in Germany: Results from the Micra Registry |
| V1783 |
Four years Follow-Up of Leadless Pacing System – Single center Real life experience compared to data of the prospective trial |
| V1784 |
First 4 Year Follow Up Data for TPS Leadless Pacing: Device Performance, Left Ventricular Function and RV Pacing Demand A Large Two Center Experience |
| V1785 |
Der subxiphoidale Herzschrittmacher mit epikardialer Elektrode – eine sichere Therapie zur Überbrückung schrittmacherabhängiger Patienten nach Systemexplantation |
| V1787 |
Impact of cancer and cardiotoxic chemotherapy on cardiac regenerative capacity |
| V1788 |
A Novel Doxorubicin-Mediated Cardiotoxicity Therapy based on circular RNA circ-INSR |
| V1789 |
Cardiotoxicity of FGF23 – Is phosphate the key mediator? |
| V1790 |
Early detection and prevention of cardiotoxicity in survived cancer patients |
| V1791 |
Association of Lipoprotein(a)-levels with intrinsic and on-clopidogrel platelet reactivity |
| V1792 |
The oxysterol 27-hydroxycholesterol is elevated in patients with relevant coronary artery disease |
| V1793 |
Cholesterol Absorption Is Associated With In-Stent Restenosis In Stable Coronary Artery Disease: An OCT Study |
| V1794 |
Measurement uncertainty and reality. How reliable is the LDL-C determination in view of the new ESC/EAS guidelines for the management of dyslipidemias? |
| V1795 |
Frequency and dosing impact of the novel lipid lowering agent’s proprotein convertase subtilisin-kexin type 9 inhibitors to reducing low-density lipoprotein cholesterol (LDL-C) in high risk patients |
| V1796 |
Das aktuelle LDL-C-Ziel < 1,4mmol/l der ESC wird bei weniger als 16% der Patienten mit KHK trotz effektiver lipid-senkender Therapie erreicht: Daten aus dem LLT-R-Register |
| V1797 |
Unterschätzen die ESC Guidelines das kardiovaskuläre Risiko bei Lipoproteinämie (a)? |
|
Analyse der Prävalenz der Lipoproteinämie (a) >180 mg/dl anhand von real-world-Daten von über 52.800 Patienten |
| V1798 |
Cost-effectiveness & freedom from apheresis through proprotein convertase subtilisin/kexine 9 Inhibitor in very high cardiovascular risk patients with lipid apheresis: 2-years real world experience |
| P1799 |
Get with the Guidelines-Heart Failure (GWTG-HF) Risk Score in Patients Undergoing Transcatheter Tricuspid Valve Repair (TTVR) |
| P1800 |
Changes of sympathetic nerve activity in patients with secondary functional tricuspid regurgitation undergoing interventional repair |
| P1801 |
Analyse des rechten Herzens bei Patienten mit fortgeschrittener Leberzirrhose vor Lebertransplantation mittels Speckle-Tracking-Echokardiographie |
| P1802 |
Calculation of right ventricular volumes and function by a simplified formula based on basal diameter and length in 4-chamber view in comparison to conventional analysis by cardiac magnetic resonance |
| P1803 |
Quantitative echocardiographic analysis of the right atrial size reflects the severity of histopathological confirmed fibrosis in patients undergoing cardiac surgery |
| P1804 |
Functional imaging of tricuspid regurgitation and tricuspid valve: Echocardiography versus Tomography |
| P1805 |
Incidence and clinical impact of adverse events associated with intraprocedural transesophageal echocardiography in structural heart disease interventions |
| P1806 |
Does coronary artery disease influence outcome of Mitraclip® patients? |
| P1807 |
Outcomes of nonagenarians undergoing percutaneous mitral valve repair |
| P1808 |
Akute Nierenschädigung nach Transkatheter-Aortenklappenimplantation (TAVI) – Inzidenz, potenzielle Ursachen und Prognose |
| P1809 |
Metabolomic profiling in patients with severe aortic stenosis and the impact of transcatheter aortic valve implantation |
| P1810 |
NLRP3 Inflammasom activation contributes to aortic valve stenosis development in mice |
| P1811 |
Incidence, predictors and outcome of delirium in patients undergoing transcatheter edge-to-edge mitral valve repair with MitraClip: A prospective observational single centre study |
| P1812 |
High H2FPEF score is an independent predictor of adverse outcome in patients with preserved ejection fraction undergoing TAVI |
| P1813 |
Validation of the Toronto Aortic Stenosis Quality of Life (TASQ) Questionnaire in patients undergoing Aortic Valve Replacement – Results of the TASQ Registry |
| P1814 |
Impact of left atrial diameter on outcome in patients undergoing edge-to-edge mitral valve repair: Results from the German transcatheter mitral valve interventions registry |
| P1815 |
Mitral valve-in-valve and valve-in-ring procedures using four different types of transcatheter heart valves via transseptal or transapical access |
| P1816 |
Comparison of preprocedural and intraprocedural mitral regurgitation severity in patients undergoing transcutaneous edge-to-edge mitral valve repair |
| P1817 |
Comprehensive assessment of anatomic predictors for outcome after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation |
| P1818 |
Association of mean pressure gradient, pressure half time, regurgitant area, and heart rate with mitral valve orifice area prior and post edge-to-edge mitral valve repair |
| P1819 |
Long-term prognostic impact of invasive exercise hemodynamics in patients with severe mitral regurgitation and preserved ejection fraction |
| P1820 |
Left Atrial Function Predicts Clinical Outcome Following Transcatheter Mitral Valve Repair |
| P1821 |
Invasive left atrial pressure and echocardiographic right ventricular function predict progression or regression of tricuspid regurgitation in patients undergoing percutaneous mitral valve repair |
| P1822 |
Prevalence and clinical impact of persistent iatrogenic atrial septal defects (iASD) after MitraClip procedure in the long term follow up |
| P1823 |
Iatrogenic atrial septal defect persistence after percutaneous mitral valve repair: a meta-analysis |
| P1824 |
Clinical and echocardiographic outcomes after treatment of patent foramen ovale with two transcatheter occlusion devices: Single center observational study |
| P1825 |
First European single-center experience with the second generation Watchman Flex occluder: Results from our 3-Months Follow-up |
| P1826 |
PFO and ASD occluder – Histopathology in 61 human explanted devices |
| P1827 |
Der interventionelle Verschluss des linken Vorhofohrs als Alternative zur dauerhaften oralen Antikoagulation bei Patienten mit Vorhofflimmern – Patientenperspektive |
| P1828 |
Timing of LAAO in TAVR-Patients with atrial fibrillation at high risk for bleeding |
| P1829 |
Pulmonary hypertension and elevated transpulmonary pressure are associated with increased mortality after transcatheter edge-to-edge tricuspid valve repair of severe tricuspid regurgitation |
| P1830 |
Impact of successful percutaneous coronary revascularization on outcomes after transcatheter aortic valve implantation (TAVI) |
| P1831 |
Staged High Risk Percutaneous Coronary Intervention Before Transcatheter Aortic Valve Intervention using Impella Ventricular Assist Device in Patients with Severe Aortic Stenosis |
| P1832 |
Single-center experience with different regimes of antiplatelet therapy and oral anticoagulation in high risk patients after transcatheter aortic valve implantation |
| P1833 |
Plug-based versus suture-based vascular closure after transcatheter aortic valve implantation: Initial experience from a single high-volume center |
| P1834 |
Bleeding complications drive early mortality of patients with atrial fibrillation after transcatheter aortic valve replacement |
| P1835 |
Transaxillary transcatheter aortic valve implantation as first line alternative to transfemoral access: single center experience |
| P1836 |
Ein Scorecard-System zur Qualitätserhaltung und Qualitätsoptimierung bei Minimierung der Verweildauer von Transkatheter-Aortenklappenersatz (TAVI) Patienten |
| P1837 |
Cracking valves: Transcather aortic valve-in-valve implantation with bioprosthetic ring fracturing |
| P1838 |
Prediction of long-term mortality after Transcatheter Aortic Valve Implantation(TAVI): proposal of a simple practical sum-score system |
| P1839 |
LV-AO angle is associated with platelet reactivity in patients with aortic stenosis |
| P1840 |
Klinischer Nutzen, Zuverlässigkeit sowie prognostische Aussagekraft des Point-of-care-Tests „CT-ADP“ bei TAVI-Patienten mit hochgradiger Aortenklappenstenose |
| P1841 |
Long-term outcome in repair of tricuspid aortic valves |
| P1842 |
Relation between reverse remodelling and outcome after TAVR |
| P1843 |
Echocardiographic predictors of short- and long-term outcome in patients undergoing transcatheter aortic valve implantation |
| P1844 |
Ist die mittlere Gradientenreduktion noch ein akkurater Surrogatparameter für eine erfolgreiche perkutane Aortenklappenvalvuloplastie? |
| P1845 |
Increased Bilirubin is Associated With Early and Midterm Mortality in Patients Receiving Transfemoral Transcatheter Aortic Valve Replacement |
| P1846 |
Risk estimation in older patients in primary and secondary prevention using the general ESC SCORE or the specific ESC SCORE O.P. |
| P1847 |
Predicting outcome in patients with symptomatic coronary artery disease: A comparison of available risk assessment scores |
| P1848 |
Higher BNP/ NT-pro BNP levels stratify prognosis in patients with coronary artery disease but without heart failure. |
| P1849 |
Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in heart failure after myocardial infarction – Insights from the EPHESUS trial |
| P1850 |
Prospective validation of an acoustic-based system for the detection of obstructive coronary artery disease in a high prevalence population(VALIDATE) |
| P1851 |
Impact of guideline adherent secondary prevention therapy on prognosis after coronary artery bypass graft surgery. Results of the TiCAB trial |
| P1852 |
Prognostic relevance of EXCEL trial´s biomarker-based endpoint definition of CABG-related perioperative myocardial infarction (type 5) |
| P1853 |
TRoponin of Unknown origin in STroke evaluated by cardiac Magnetic resonance Imaging – the TRUST-MI study |
| P1854 |
Influence of Myocardial Damage on Serum Procalcitonin in ST-Elevation Myocardial Infarction |
| P1855 |
Residual Inflammatory Risk at 12 months in the SPUM-ACS cohort |
| P1856 |
iPSC-derived endothelial cells from ACS patients display stronger inducible ICAM1 and E-Selectin upregulation and gap closure delay under inflammatory stimulation compared to healthy controls |
| P1857 |
The transcriptomic landscape of cell-sorted reticulated and non-reticulated human platelets from healthy donors, patients with chronic coronary syndrome or patients with STEMI |
| P1858 |
Different definitions of acute kidney failure impact prevalence and prognosis in invasively managed ACS patients |
| P1859 |
Trimethylamine N-oxide (TMAO) and ADP-induced platelet reactivity are independent risk factors for all-cause and cardiovascular mortality |
| P1860 |
Gremlin-1 and Macrophage Migration Inhibitory Factor Polymorphisms are associated with adverse clinical outcome in patients with symptomatic coronary artery disease |
| P1861 |
Outcomes of coronary catheterization in high or low volume hospitals in Germany |
| P1862 |
Identification of specific coronary artery disease phenotypes predicting cardiovascular outcome |
| P1863 |
Characteristics and possible implications of coronary tortuosity in overweight patients undergoing coronary angiography with exclusion of coronary artery disease |
| P1864 |
Invasive assessment of patients with angina and unobstructed coronary arteries: Safety and diagnostic yield of interventional coronary function testing |
| P1865 |
Significant Radiation Dose Reduction Using a Novel Angiography Platform in Patients Undergoing Diagnostic Invasive Coronary Angiography |
| P1866 |
Determinants of radiation exposure during coronary angiography – insights from the RAMBO trial |
| P1867 |
Effects of a fixed heparin dose on anticoagulation in patients undergoing invasive coronary procedures |
| P1868 |
Influence of methodological characteristics of trials on treatment effects of invasive cardiovascular interventions compared with placebo procedures: Stratified analyses and meta-regression |
| P1869 |
Clinical predictors of lesion-specific ischemia as determined by fractional flow reserve in a large multicenter cohort: Results of the German F(FR)² Registry |
| P1870 |
Assessment of non-culprit lesions by Quantitative Flow Ratio predicts outcome in patients with acute coronary syndrome |
| P1871 |
Extent of plaque calcification and lesion length, but not features of plaque vulnerability predict mortality in patients with type 2 diabetes following coronary intervention |
| P1872 |
Impact of Diabetes Mellitus on Outcome in Patients undergoing High-Risk Interventional Coronary Procedures |
| P1873 |
Der spannende Fall: Retrograde CTO mit Besonderheiten! |
| P1874 |
Quantitative Flow Ratio assessment of ACS-causing culprit vessels after PCI provides risk for target vessel failure |
| P1875 |
Long term outcome of patients with calcified coronary lesions treated with intravascular lithotripsy: Data from a prospective, observational, multicenter registry |
| P1876 |
In patients admitted with acute heart failure in-hospital changes of iron deficiency are associated with inflammation biomarkers and depend on cardiac phenotype |
| P1877 |
Presentation characteristics and outcomes in patients with ischaemic vs. non-ischaemic cardiogenic shock. |
| P1878 |
Assessment of sepsis as a cause of death in patients treated with Impella for cardiogenic shock – a pilot investigation |
| P1879 |
Characteristics of myocardial work (MyW) in acutely decompensated heart failure patients |
| P1880 |
Longitudinal changes in left ventricular function in patients hospitalized for acutely decompensated heart failure with reduced ejection fraction |
| P1881 |
Dynamic variation of systolic ejection time during hospitalization and recompensation in patients with heart failure with reduced ejection fraction |
| P1882 |
Myocardial Work in acute decompensated heart failure patients – what happens during recompensation? |
| P1883 |
Langzeitoutcome nach dialysepflichtigem Nierenversagen auf einer internistischen Intensivstation – Einfluss des kardiogenen Schocks auf die Prognose |
| P1884 |
Prevalence and determinants of bone disease in patients with chronic heart failure – a prospective cohort study |
| P1885 |
Single nuclei sequencing reveals novel insights into the age-dependent regulation of cell populations and signatures in the heart of humans |
| P1886 |
Cardiac Optineurin modulates cardiac autophagy and apoptosis and is involved in the development and progression of heart failure |
| P1887 |
Myomasp, a novel regulator of M-band associated signaling pathways, affects cardiac hypertrophy and is required for proper aged heart function in vivo |
| P1888 |
Esophageal Cancer Related Gene-4 affects cardiac ion channel expression and function by modulating expression of inflammatory factors |
| P1889 |
Patient-specific induced pluripotent stem cells and iPSC-derived cardiomyocytes as tools to discover new treatment options for Fabry disease |
| P1890 |
Increased myofilament Ca2+ sensitivity induces creatine kinase oxidation and inactivation in hypertrophic cardiomyopathy through mitochondrial redox mismatch |
| P1891 |
Extended infusion of serelaxin has no effect on pressure overload induced heart failure in mice |
| P1892 |
Comparison of the radial versus femoral access in patients treated with percutaneous coronary intervention and scaffold implantation – results from the German Austrian ABSORB registry (GABI-R) |
| P1893 |
Impact of vascular access on contrast-associated acute kidney injury in patients with coronary artery bypass graft undergoing coronary catheterization |
| P1894 |
Arterieller Zugang vom linken Arm führt zu einem höheren Prozedurerfolg. Retrospektive Analyse von 1000 Untersuchungen |
| P1895 |
Frequency and safety of femoral vs. radial access for percutaneous coronary intervention (PCI): Results from a large monitor-controlled German registry (QuIK) |
| P1896 |
Radial first?! Analyzing the “Bremen STEMI Registry” for efficacy and safety endpoints |
| P1897 |
Impact of radial versus femoral access within a guideline-conform ST-elevation myocardial infarction network: a prospective observational registry study |
| P1898 |
Incidence and predictors of radial artery occlusion following transradial coronary catheterization – first insights of the ProRadial study |
| P1899 |
Radial versus femoral access for coronary catheterization in patients with a history of coronary bypass surgery |
| P1900 |
Impact of cigarette smoke compared to next generation tobacco and nicotine products on endothelial function |
| P1901 |
Noise annoyance may contribute to cardiovascular morbidity and mortality by increasing levels of midregional pro atrial natriuretic peptide |
| P1902 |
Prospektive Untersuchung des kardiovaskulären Belastungsprofils im Luftrettungsdienst in Deutschland |
| P1903 |
Prolonged exposure to noise pollution causes an increase in inflammatory signaling in the setting of hypertension |
| P1904 |
Noise-induced vascular dysfunction, oxidative stress and inflammationare improved by pharmacological heme oxygenase-1 induction |
| P1905 |
Inflammation rather than use of NSAIDs increase risk of myocardial infarction |
| P1906 |
Patients with Peripartum Cardiomyopathy display a high incidence of subfertility and fertility treatments |
| P1907 |
Impact of antithrombotic therapy on procedural safety of catheter ablation of ventricular arrhythmias |
| P1908 |
Resolution intrakardialer Thromben in Abhängigkeit der oralen systemischen Antikoagulation mit NOAKs und Marcumar |
| P1909 |
Association of clinic and ambulatory heart rate parameters with mortality |
| P1910 |
Feasibility of RV resynchronization in HFrEF patients with recurrent right heart decompensations |
| P1911 |
Geosimulation based deployment parameter of AED equipped mobile responders for optimizing the survival rate of out-of-hospital cardiac arrest |
| P1912 |
Endo- and epicardial mapping of spontaneous ventricular fibrillation during acute myocardial infarction in a porcine model |
| P1913 |
Differentiating Narrow Complex Tachycardias With A Smartphone ECG – A bridge too far? |
| P1914 |
Signal quality in single-lead electrocardiograms in an atrial fibrillation pharmacy-based mass-screening |
| P1915 |
Detection of atrial fibrillation by long-term cardiac monitoring after embolic stroke of undetermined source (ESUS) |
| P1916 |
The role of implantable loop recorders and home monitoring after detection of atrial fibrillation in patients with cryptogenic stroke: Results from a prospective single-center database |
| P1917 |
Detection of arrhythmia-triggered and hemodynamically relevant worsening of heart failure patients through continuous ECG- and PAP-Monitoring |
| P1918 |
Implantable loop recorder in patients with syncope of unknown origin: Results from a single-center cohort |
| P1919 |
Deceleration capacity for rapid risk stratification in patients with acute ischemic stroke |
| P1920 |
Outcome after ICD exchange in the elderly |
| P1921 |
Atrial Fibrillation Increases Risk for Recurrent Ventricular Tachyarrhythmias in ICD Recipients |
| P1922 |
Are there shock incidence and mortality differences in primary prevention patients regarding device type and ischemia? A NORDIC ICD sub-study |
| P1923 |
Urinary NT-proBNP compared head-to-head to plasmatic NT-proBNP in a real life collective with an implantable cardioverter defibrillator |
| P1924 |
Hypokalemia but Not Hyperkalemia is Associated with Recurrences of Ventricular Tachyarrhythmias in ICD Recipients |
| P1925 |
Neutraler Effekt von Herzglykosiden auf Mortalität, MACCE und Rehospitalisierungsraten bei ICD und CRT-ICD Patienten: Ein-Jahres-Follow-Up Ergebnisse des Deutschen DEVICE Registers |
| P1926 |
Implantable cardioverter-defibrillator for secondary prevention in octogenarians |
| P1927 |
Post-Mortem Cardiovascular Implantable Electronic Device Interrogation in Patients undergoing autopsy |
| P1928 |
Concomitant treatment with proton pump inhibitors and cephalosporins does not enhance QT associated proarrhythmia in isolated rabbit hearts |
| P1929 |
Preliminary safety data on the selective estrogen receptor degrader fulvestrant in an experimental whole-heart model |
| P1930 |
Divergent electrophysiological effects of loperamide and naloxone in a sensitive whole-heart model |
| P1931 |
A cellular model of Brugada Syndrome with CACNB2 mutation of human-induced pluripotent stem cell-derived cardiomyocytes |
| P1932 |
Studying Brugada Syndrome with a SCN1B compound mutation in human-induced pluripotent stem cell-derived cardiomyocytes |
| P1933 |
Hyperthermia enhances phenotypic changes of Brugada Syndrome in human-induced pluripotent stem cell-derived cardiomyocytes |
| P1934 |
Gen-editing to model Short QT Syndrome type 5 using human-induced pluripotent stem cell-derived cardiomyocytes |
| P1935 |
A cellular model of Brugada Syndrome with SCN5A polymorphism using human-induced pluripotent stem cell-derived cardiomyocytes |
| P1936 |
Are computer algorithms able to guide ablation procedures and possibly predict future arrhythmia? |
| P1937 |
Dipole Density Mapping for Persistent Atrial Fibrillation: Procedural Insights and First Long Time Outcome Data |
| P1938 |
Clinical outcome of pulmonary vein isolation for atrial fibrillation treatment guided by the new direct sense catheter technology – a single-center two year experience |
| P1939 |
Prediction of Atrial Arrhythmogenic Low-Voltage Substrate at High-Density Invasive Voltage-Mapping by Echocardiographic Parameters in Patients with Persistent Atrial Fibrillation |
| P1940 |
Clinical importance of wide circumferential catheter ablation and antral re-isolation in case of recurrent atrial fibrillation ablation after previous PVI |
| P1941 |
Coronary-Sinus Signal Amplitude can predict leftatrial Fibrosis |
| P1942 |
Characterization of temporal electrical activity patterns for detection of critical isthmus regions of recurrent atypical atrial flutter |
| P1943 |
Investigation of local rate dependency of atrial conduction velocity and voltage as means to pinpoint diseased tissue |
| P1944 |
Early commercial experience with a novel balloon-expandable transcatheter heart valve: the first 53 patients |
| P1945 |
Long-term valve performance of TAVR compared to SAVR in patients with severe symptomatic aortic stenosis – a propensity score matched analysis of the TAVIK Registry |
| P1946 |
Performance comparison of classical surgical and modern interventional transcatheter aortic valve replacement (TAVR) risk models for prediction of 30-day mortality in a German cohort of 1,569 patients |
| P1947 |
Impact of valve choice on clinical results after porcine versus bovine aortic valve replacment- Hospital results and long-term follow-up |
| P1948 |
Comparison of self-expanding and the balloon expandable transcatheter heart valve in highly calcified aortic stenosis |
| P1949 |
Long-term outcomes with new generation prostheses in patients undergoing transcatheter aortic valve implantation – Edwards Sapien 3 vs. Medtronic Evolut R |
| P1950 |
Impact of embolic protection and repositioning on stroke in patients treated with the Lotus valve in routine clinical practice: Insights from the RESPOND post-market study |
| P1951 |
Prevalence and prognostic impact of left ventricular outflow tract calcification in patients with severe aortic stenosis undergoing TAVI using second-generation devices |
| P1952 |
Pulmonary arterial hypertension in klotho-deficient mice: a murine model of premature aging |
| P1953 |
Plasma proteome analysis in chronic thromboembolic pulmonary hypertension for new diagnostic targets |
| P1954 |
Einfluss der pulmonalen Hypertonie auf die linksventrikuläre Steifheit: eine Grosstierstudie |
| P1955 |
Do inpatients receive prophylactic treatment for thrombotic events based on their risk for developing them? A retrospective, monocentric study |
| P1956 |
Hemodynamic phenotypes and survival in patients with systemic sclerosis– the impact of the new definition of pulmonary arterial hypertension |
| P1957 |
Effects of short-term therapy with high dose nutritional inorganic nitrite and nitrate on vascular dysfunction, oxidative damage and epigenetic regulation in experimental arterial hypertension |
| P1958 |
Reactivity of pulmonary arterial capacitance to glycerol trinitrate is associated with survival in patients with postcapillary pulmonary hypertension across the ejection fraction spectrum |
| P1959 |
Levels of soluble suppression-of-tumorigenesis-2 are associated with impaired right ventricular function in patients with preserved ejection fraction |
| P1960 |
Development and validation of a risk model for primary graft failure after heart transplantation and comparison to the RADIAL risk score |
| P1961 |
Development of a new risk prediction algorithm for heart failure patients from a systematic review |
| P1962 |
Prognostic impact of myocardial performance index in chronic heart failure – Results from the MyoVasc Study |
| P1963 |
Anaemia, Renal Insufficiency and Iron Deficiency in Patients Hospitalised for Acute Cardiac Decompensation – Prevalence and Impact on In-Hospital Worsening Condition |
| P1964 |
Comparative performance analysis of GRACE and ACTION risk models for prediction of in-hospital mortality in a German patient population with acute coronary syndrome |
| P1965 |
Acute kidney injury after cardiac surgery – prediction based on scores, net values or both? |
| P1966 |
Telemonitoring of patients with chronic heart failure: Long term results of mortality and cost analysis |
| P1967 |
Remote monitoring with adequate reaction to alerts was associated with improved outcomes in chronic heart failure: Results from the OptiLink HF study |
| P1968 |
Mehr Sicherheit durch schnelle Datenübertragung: Patienten-App für Kunstherzpatienten im klinischen Einsatz |
| P1969 |
Comparison of vector derived smart device enabled electrocardiogram with standard 12 lead ecg during ergometer stress testing |
| P1970 |
Three-dimensional printing for diagnosis of left ventricular outflow obstruction and re-do surgery planning Diagnosis and Surgery Planning using 3D Printing technologies on the case of a complex LVOTO |
| P1971 |
Impact of transmission day of remote monitoring on patient contact: Results from the OptiLink HF study |
| P1972 |
Telemedizinische Betreuung von Patienten mit chronischer Herzinsuffizienz senkt die Mortalität signifikant um ein Drittel: Langzeitergebnisse eines großen Versorgungskollektivs |
| P1973 |
Radiofrequency Needle for Transseptal Puncture using non-fluoroscopic technique |
| P1974 |
Impact of re-definition of paroxysmal and persistent atrial fibrillation in the 2012 and 2016 European Society of Cardiology atrial fibrillation guidelines on outcomes after pulmonary vein isolation |
| P1975 |
Circumferential pulmonary vein ablation with or without a linear lesion at the left atrial roof for catheter ablation of persistent atrial fibrillation (9-year follow-up) |
| P1976 |
Recurrent atrial fibrillation after PVI: Are the pulmonary veins or atrial substrate responsible? |
| P1977 |
Inducibility of atrial fibrillation following pulmonary vein isolation predicts recurrences of atrial fibrillation: a meta-analysis |
| P1978 |
Predicting Contact Force by Deformation of the TactiCath SE Catheter: Lessons learned by ex vivo Experiments |
| P1979 |
What is responsible for the increased Prevalence of Atrial Fibrillation (AF) in Congenital Heart Disease? – Insights from Bipolar High Density (HD) Electro Anatomical Mapping for Atrial Fibrosis |
| P1980 |
First experience with the new X3 generation laserballoon |
